{"SLR NAME":"Predicting mortality in severe COVID-19: a systematic review of the literature and external validation of clinical prediction rules for mortality from SARS-CoV-2 infection","References":[{"title1":"The Prognostic Nutritional Index is associated with mortality of COVID?19 patients in Wuhan, China","References":[{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Acute gastrointestinal injury in critically ill patients with coronavirus disease 2019 in Wuhan, China","References":[]},{"title2":"Acute kidney injury at early stage as a negative prognostic indicator of patients with COVID-19: a hospital-based retrospective analysis","References":[]},{"title2":"Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan, China","References":[]},{"title2":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score"},{"title3":"Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure"}]},{"title2":"Acute liver injury and its association with death risk of patients with COVID-19: a hospital-based prospective case-cohort study","References":[]},{"title2":"Cytokine release syndrome in severe COVID-19","References":[{"title3":"Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis"},{"title3":"Viral RNA Load in Plasma Is Associated with Critical Illness and a Dysregulated Host Response in COVID-19"},{"title3":"Endotoxin and Cytokine Reducing Properties of the oXiris Membrane in Patients with Septic Shock: A Randomized Crossover Double-Blind Study"},{"title3":"Extracorporeal Immune Modulation in COVID-19 Induced Immune Dysfunction and Secondary Infections: the Role of oXiris  Membrane"},{"title3":"Renal Complications and Their Prognosis in Korean Patients with Middle East Respiratory Syndrome-Coronavirus from the Central MERS-CoV Designated Hospital"},{"title3":"Is There a Role for Blood Purification Therapies Targeting Cytokine Storm Syndrome in Critically Severe COVID-19 Patients?"},{"title3":"Continuous Renal Replacement Therapy in Cytokine Release Syndrome Following Immunotherapy or Cellular Therapies?"},{"title3":"The Role of IL-6 and Other Mediators in the Cytokine Storm Associated with SARS-CoV-2 Infection"},{"title3":"Efficacy of Continuous Renal Replacement Therapy in the Treatment of Severe Acute Pancreatitis Associated Acute Respiratory Distress Syndrome"},{"title3":"An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival"},{"title3":"Changes of Serum Procalcitonin (PCT), C-Reactive Protein (CRP), Interleukin-17 (IL-17), Interleukin-6 (IL-6), High Mobility Group Protein-B1 (HMGB1) and D-Dimer in Patients with Severe Acute Pancreatitis Treated with Continuous Renal Replacement Therapy (CRRT) and Its Clinical Significance"},{"title3":"A Multi-center Cross-Sectional Study on Blood Purification Among Adult Patients in Intensive Care Unit in China: a Study Protocol"},{"title3":"Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19"},{"title3":"Vaccine Breakthrough Infections with SARS-CoV-2 Variants"},{"title3":"6-month Consequences of COVID-19 in Patients Discharged from Hospital: a Cohort Study"},{"title3":"Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China"},{"title3":"Coronavirus Disease 2019 (COVID-19): Cytokine Storms, Hyper-Inflammatory Phenotypes, and Acute Respiratory Distress Syndrome"},{"title3":"Low-to-moderate Dose Corticosteroids Treatment in Hospitalized Adults with COVID-19"},{"title3":"Clearance of Inflammatory Cytokines in Patients with Septic Acute Kidney Injury during Renal Replacement Therapy Using the EMiC2 Filter (Clic-AKI Study)"},{"title3":"COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression"},{"title3":"Extracorporeal Blood Purification Therapies for Sepsis"},{"title3":"COVID-19: What Type of Cytokine Storm Are We Dealing with?"},{"title3":"Efficacy and Safety of the Monoclonal Anti-tumor Necrosis Factor Antibody F(ab')2 Fragment Afelimomab in Patients with Severe Sepsis and Elevated Interleukin-6 Levels"},{"title3":"High-Dose versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial"},{"title3":"The Deregulated Immune Reaction and Cytokines Release Storm (CRS) in COVID-19 Disease"},{"title3":"Removal of Inflammatory Cytokines and Endotoxin by Veno-Venous Continuous Renal Replacement Therapy for Burned Patients with Sepsis"},{"title3":"Extracorporeal Blood Purification Is Associated with Improvement in Biochemical and Clinical Variables in the Critically-Ill COVID-19 Patients"},{"title3":"Factors Leading to High Morbidity and Mortality of COVID-19 in Patients with Type 2 Diabetes"},{"title3":"Extracorporeal Blood Purification in Moderate and Severe COVID-19 Patients: A Prospective Cohort Study"},{"title3":"Continuous Renal Replacement Therapy with oXiris  Membrane in Severe Ebstein-Barr Virus-Mediated Hemophagocytic Lymphohistiocytosis: A Case Report"},{"title3":"oXiris  Use in Septic Shock: Experience of Two French Centres"},{"title3":"Effects of Acute Kidney Injury on Acute Pancreatitis Patients' Survival Rate in Intensive Care Unit: A Retrospective Study"},{"title3":"Characterization of the Cytokine Storm Reflects Hyperinflammatory Endothelial Dysfunction in COVID-19"},{"title3":"Continuous Renal Replacement Therapy with the Adsorbing Filter oXiris in Septic Patients: A Case Series"},{"title3":"Corticosteroid Use in COVID-19 Patients: a Systematic Review and Meta-Analysis on Clinical Outcomes"},{"title3":"Blood Purification Therapy with a Hemodiafilter Featuring Enhanced Adsorptive Properties for Cytokine Removal in Patients Presenting COVID-19: a Pilot Study"},{"title3":"Cytokine Levels in Sputum, Not Serum, May Be More Helpful for Indicating the Damage in the Lung and the Prognosis of Severe COVID-19 - A Case Series"},{"title3":"The Effectiveness of Continuous Renal Replacement Therapy in Critical COVID-19 Patients with Cytokine Release Syndrome: a Retrospective, Multicenter, Descriptive Study from Wuhan, China"},{"title3":"Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: a Single-Centered, Retrospective, Observational Study"},{"title3":"The Therapeutic Effect of High-Volume Hemofiltration on Sepsis: a Systematic Review and Meta-Analysis"},{"title3":"Association of Inflammatory Markers with the Severity of COVID-19: A Meta-Analysis"},{"title3":"The Absorbing Filter Oxiris in Severe Coronavirus Disease 2019 Patients: A Case Series"}]},{"title2":"COVID-19: a new virus, but a familiar receptor and cytokine release syndrome","References":[{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines"},{"title3":"Chimeric antigen receptor T-cell therapy - assessment and management of toxicities"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"}]},{"title2":"IL-6 in inflammation, immunity, and disease","References":[]},{"title2":"IL-6 pathway in the liver: from physiopathology to therapy","References":[]},{"title2":"Targeting interleukin-6 in inflammatory autoimmune diseases and cancers","References":[]},{"title2":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","References":[]},{"title2":"Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?","References":[{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"High viral load and respiratory failure in adults hospitalized for respiratory syncytial virus infections"},{"title3":"Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations"},{"title3":"Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon"},{"title3":"JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa"}]},{"title2":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","References":[]},{"title2":"The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Management of severe acute respiratory infection when novel coronavirus (ncov) infection is suspected (accessed Jan 20, 2020)."},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013"},{"title3":"The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients"},{"title3":"What to do next to control the 2019-nCoV epidemic?"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor"},{"title3":"The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression"},{"title3":"Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer"},{"title3":"Infections as a major preventable cause of human cancer"},{"title3":"Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk"},{"title3":"Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis"},{"title3":"Chronic inflammation and cancer"},{"title3":"Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes"},{"title3":"Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications"},{"title3":"The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients"},{"title3":"Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio"},{"title3":"Elevated absolute monocyte count, absolute neutrophil count, and neutrophil-to-lymphocyte ratio as prognostic factors in locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy"},{"title3":"The neutrophil to lymphocyte ratio is superior to other inflammation-based prognostic scores in predicting the mortality of patients with pneumonia"},{"title3":"Neutrophil-to-monocyte-plus-lymphocyte ratio as a potential marker for Discriminating pulmonary tuberculosis from nontuberculosis infectious lung diseases"},{"title3":"High neutrophil-to-lymphocyte ratio predicts stroke-associated pneumonia"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","References":[{"title3":"The neutrophil-to-lymphocyte ratio: a narrative review"},{"title3":"Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction"},{"title3":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer"},{"title3":"Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage"},{"title3":"Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severeacute-respiratoryinfection-when-novelcoronavirus-(ncov)-infection-is-suspected. (accessed March 29, 2020). 2020."},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. https://www.whoint/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117(accessed March 29, 2020). 2020."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study"},{"title3":"Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"}]},{"title2":"Potential factors for prediction of disease severity of COVID-19 patients","References":[]},{"title2":"Interleukin-6 in COVID-19. A systematic review and meta-analysis","References":[{"title3":"Lescure, F. X., H. Honda, R. A. Fowler, J. S. Lazar, G. Shi, P. Wung, N. Patel, O. Hagino, and Covid-Global Study Group Sarilumab. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet respiratory medicine.2021; 9(5): 522-532. (https://clinicaltrials.gov/ct522/show/results/NCT04327388)."},{"title3":"Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial"},{"title3":"Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial"},{"title3":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes"},{"title3":"Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis"},{"title3":"Clinical Nutrition in Critical Care Medicine - Guideline of the German Society for Nutritional Medicine (DGEM)"},{"title3":"Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis"},{"title3":"Intention-to-treat concept: A review"},{"title3":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations"},{"title3":"Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia: two randomised controlled trials of the CORIMUNO-19 Collaborative Group"},{"title3":"Horby, P., et al. Dexamethasone in Hospitalized Patients with Covid-19. New England journal of medicine.2021; 384(8): 693-704. doi:10.1056/NEJMoa2021436."},{"title3":"Correlation between vaccine coverage and the COVID-19 pandemic throughout the world: Based on real-world data"},{"title3":"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19"},{"title3":"Post-acute sequelae of COVID-19 infection"},{"title3":"Lamontagne, F., et al. A living WHO guideline on drugs for covid-19. Bmj.2020; 370: m3379. doi:10.1136/bmj.m3379."},{"title3":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration"},{"title3":"Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range"},{"title3":"Mastrorosa, I., et al. SARILUMAB PLUS STANDARD of CARE (SOC) VERSUS SOC for SEVERE COVID-19 (ESCAPE STUDY). Topics in antiviral medicine.2022; 30(1 SUPPL): 178. (https://trialsearch.who.int/Trial172.aspx?TrialID=EUCTR2020-001390-001376-IT)."},{"title3":"McCreary, E. K., and N. J. Meyer. Covid-19 controversies: the tocilizumab chapter. BMJ.2021; 372: n244. doi:10.1136/bmj.n244."},{"title3":"NCT04409262. A controlled study on the safety and efficacy of the combination remdesivir plus tocilizumab compared with individual use of these drugs for treatment of severe COVID-19 pneumonia in hospitalized patients.2020. doi:https://clinicaltrials.gov/ct2/show/results/NCT04409262?term=NCT04409262&amp;draw=2&amp;rank=1."},{"title3":"The efficacy and safety of prokinetics in critically ill adults receiving gastric feeding tubes: A systematic review and meta-analysis"},{"title3":"Rosas, I. O., et al. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. New England journal of medicine.2021; 384(16): 1503-1516. (https://clinicaltrials.gov/ct1502/show/results/NCT04320615)."},{"title3":"Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: a Randomized Clinical Trial"},{"title3":"Sanchez Diaz, P., P. Molinero Sander, R. De La Oliva, P. Serrano, A. Suarez-de-la-Rica, E. Maseda, and I. Falces Romero. Secondary infection in mechanically ventilated, critically ill-patients with COVID-19. Intensive Care Medicine Experimental. Conference: 33rd European Society of Intensive Care Medicine Annual Congress, ESICM.2020; 8(SUPPL 2)."},{"title3":"Schulz, K. F., D. G. Altman, and D. Moher. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS medicine.2010; 7(3): e1000251. doi:10.1371/journal.pmed.1000251."},{"title3":"Sivapalasingam, S., et al. Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.2022; 75(1): e380-e388. (https://clinicaltrials.gov/ct382/show/results/NCT04315298?term=NCT04315298&amp;draw=04315292&amp;rank=04315291). doi:10.1093/cid/ciac153."},{"title3":"Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial"},{"title3":"Tocilizumab for treatment of mechanically ventilated patients with COVID-19"},{"title3":"Sterne, J. A. C., et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj.2019; 366: l4898. doi:10.1136/bmj.l4898."},{"title3":"Veiga, V. C., et al. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ.2021; 372: n84. (https://clinicaltrials.gov/ct82/show/NCT04403685)."},{"title3":"Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range"},{"title3":"Specific Interleukin-1 Inhibitors, Specific Interleukin-6 Inhibitors, and GM-CSF Blockades for COVID-19 (at the Edge of Sepsis): A Systematic Review"},{"title3":"WHO, Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. 2023. doi:https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic (5 May 2023)."},{"title3":"Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis"}]},{"title2":"Prognostic value of C-reactive protein in patients with COVID-19","References":[]},{"title2":"A novel and useful predictive indicator of prognosis in ST-segment elevation myocardial infarction, the prognostic nutritional index","References":[]},{"title2":"Prognostic nutritional index and the risk of mortality in patients with acute heart failure","References":[{"title3":"Feeding the immune system"},{"title3":"Nutrition care of patients with acute and chronic respiratory failure"},{"title3":"Immunonutrition: role in wound healing and tissue regeneration"},{"title3":"Nutritional status in recently hospitalized and free-living elderly subjects"},{"title3":"Preoperative prognostic nutritional index is a significant predictor of survival in renal cell carcinoma patients undergoing nephrectomy"},{"title3":"Decline in nutritional status is associated with prolonged length of stay in hospitalized patients admitted for 7 days or more: a prospective cohort study"},{"title3":"The relation between nutritional state and quality of life in surgical patients"},{"title3":"Wasting as independent risk factor for mortality in chronic heart failure"},{"title3":"Influence of obesity and malnutrition on acute heart failure"},{"title3":"Short-form nutrition assessment in patients with advanced heart failure evaluated for ventricular assist device placement or cardiac transplantation"},{"title3":"Nutritional risk screening in hospitalized patients with heart failure"},{"title3":"Albumin levels predict survival in patients with systolic heart failure"},{"title3":"The relationship between cholesterol and survival in patients with chronic heart failure"},{"title3":"Predictive power of the relative lymphocyte concentration in patients with advanced heart failure"},{"title3":"Determinants and prognostic impact of hyperuricemia in hospitalization for acute heart failure"},{"title3":"2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference"},{"title3":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group"},{"title3":"Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements"},{"title3":"Prognostic nutritional index predicts postoperative outcome in colorectal cancer"},{"title3":"Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics"},{"title3":"Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia"},{"title3":"Gastrointestinal and liver issues in heart failure"},{"title3":"Anemia: an indicator for malnutrition in the elderly"},{"title3":"Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure"},{"title3":"Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure"},{"title3":"A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure"},{"title3":"Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation"},{"title3":"Cardiac cachexia is associated with right ventricular failure and liver dysfunction"},{"title3":"Prognostic impact of intestinal wall thickening in hospitalized patients with heart failure"},{"title3":"Geriatric nutritional risk index predicts functional dependency and mortality in patients with heart failure with preserved ejection fraction"},{"title3":"Albumin levels predict survival in patients with heart failure and preserved ejection fraction"},{"title3":"Validation of the Get With The Guideline-Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level"}]},{"title2":"Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer","References":[{"title3":"Cancer statistics in China, 2015"},{"title3":"Global cancer statistics, 2012"},{"title3":"Adherence to stage-specific treatment guidelines for patients with colon cancer"},{"title3":"Revised TN categorization for colon cancer based on national survival outcomes data"},{"title3":"Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: analysis from Modern-Era adjuvant studies in the adjuvant colon cancer end points (ACCENT) database"},{"title3":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial"},{"title3":"Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803"},{"title3":"Capecitabine plus oxaliplatin compared with Fluorouracil/Folinic acid as adjuvant therapy for stage III colon cancer: final results of the NO16968 randomized controlled phase III trial"},{"title3":"A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites"},{"title3":"Overall survival of stage III colon cancer with only one lymph node metastasis is independently predicted by preoperative carcinoembryonic antigen level and lymph node sampling status"},{"title3":"Right-sided colon cancer and left-sided colorectal cancers respond differently to cetuximab"},{"title3":"Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer"},{"title3":"The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer"},{"title3":"Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy"},{"title3":"Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer"},{"title3":"Role of systemic inflammatory response in predicting survival in patients with primary operable cancer"},{"title3":"Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients"},{"title3":"Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection"},{"title3":"Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer"},{"title3":"Postoperative outcome after oesophagectomy for cancer: nutritional status is the missing ring in the current prognostic scores"},{"title3":"Colon cancer, version 3.2014"},{"title3":"The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer"},{"title3":"Nutritional risk screening predicts tumor response in lung cancer patients"},{"title3":"Macrophages: obligate partners for tumor cell migration, invasion, and metastasis"},{"title3":"Role of infiltrated leucocytes in tumour growth and spread"},{"title3":"The impact of the preoperative peripheral lymphocyte count and lymphocyte percentage in patients with colorectal cancer"},{"title3":"The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer"},{"title3":"Association between decreased serum albumin with risk of venous thromboembolism and mortality in cancer patients"},{"title3":"Albumin concentration controls cancer"},{"title3":"Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure"},{"title3":"Prognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma"},{"title3":"Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer"},{"title3":"Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss"},{"title3":"Inflammatory cytokines in human pancreatic cancer"},{"title3":"Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer"},{"title3":"Effectiveness of immune therapy combined with chemotherapy on the immune function and recurrence rate of cervical cancer"},{"title3":"Impact of cellular immune function on prognosis of lung cancer patients after cytokine-induced killer cell therapy"},{"title3":"A preoperative nutritional index for predicting cancer-specific and overall survival in chinese patients with laryngeal cancer: a retrospective study"},{"title3":"The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage"},{"title3":"Significance of Onodera's prognostic nutritional index in patients with colorectal cancer: a large cohort study in a single Chinese institution"},{"title3":"The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma"},{"title3":"Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer"},{"title3":"Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy"},{"title3":"Impact of home enteral nutrition in malnourished patients with upper gastrointestinal cancer: a multicentre randomised clinical trial"},{"title3":"PT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited"},{"title3":"Proposal of new classification for stage III colon cancer based on the lymph node ratio: analysis of 4,172 patients from multi-institutional database in Japan"},{"title3":"Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER):Medicare data"},{"title3":"The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database"},{"title3":"Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum"},{"title3":"Association between molecular subtypes of colorectal cancer and patient survival"}]},{"title2":"Novel immunological and nutritional-based prognostic index for gastric cancer","References":[]},{"title2":"Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy","References":[]},{"title2":"Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas","References":[]},{"title2":"Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score","References":[]},{"title2":"Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China","References":[]},{"title2":"Estimation of risk factors for COVID-19 mortality - preliminary results","References":[]},{"title2":"Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19. A rapid systematic review and meta-analysis","References":[{"title3":"WHO. Coronavirus disease (COVID-2019) Situation Report 2020 [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen."},{"title3":"WHO. Situation Report -22 2020 [Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2."},{"title3":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?"},{"title3":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia"},{"title3":"GOLD. [Available from: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf."},{"title3":"Organization WH. Chronic obstructive pulmonary disease (COPD) 2020 [Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)"},{"title3":"Support System for Early Diagnosis of Chronic Obstructive Pulmonary Disease Based on the Service-Oriented Architecture Paradigm and Business Process Management Strategy: Development and Usability Survey Among Patients and Health Care Providers"},{"title3":"Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities"},{"title3":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease"},{"title3":"Chronic obstructive pulmonary disease. 6: The aetiology of exacerbations of chronic obstructive pulmonary disease"},{"title3":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations"},{"title3":"COPD exacerbations: defining their cause and prevention"},{"title3":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement"},{"title3":"GA Wells BS, D O'Connell, J Peterson, V Welch, M Losos, P Tugwell. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [cited 2019 23/01]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp"},{"title3":"Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China"},{"title3":"Chest CT Findings in Patients with Corona Virus Disease 2019 and its Relationship with Clinical Features"},{"title3":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei, China"},{"title3":"COVID-19 and smoking: A systematic review of the evidence"},{"title3":"Chronic obstructive pulmonary disease in China: a nationwide prevalence study"},{"title3":"Global burden of COPD: systematic review and meta-analysis"},{"title3":"Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis"},{"title3":"Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China"},{"title3":"Time course and pattern of COPD exacerbation onset"},{"title3":"Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD"},{"title3":"Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization"},{"title3":"Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life"},{"title3":"Nutritional supplementation during pulmonary rehabilitation in COPD: A systematic review"},{"title3":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis"},{"title3":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis"},{"title3":"Clinical characteristics of 82 death cases with COVID-19"},{"title3":"Clinical characteristics of 101 non-surviving hospitalized patients with COVID-19: A single center, retrospective study"},{"title3":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China"},{"title3":"Clinical characteristics of 25 death cases infected with COVID-19 pneumonia: a retrospective review of medical records in a single medical center, Wuhan, China"},{"title3":"Mortality in COPD: role of comorbidities"},{"title3":"Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response"},{"title3":"On the front lines of coronavirus: the Italian response to covid-19"},{"title3":"Facing Covid-19 in Italy:Ethics, Logistics, and Therapeutics on the Epidemic's Front Line"},{"title3":"Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013"},{"title3":"Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication"},{"title3":"Sex difference and smoking predisposition in patients with COVID-19"},{"title3":"Virtually Perfect? Telemedicine for Covid-19"},{"title3":"Global use, utility, and methods of tele-health in COPD: a health care provider survey"}]},{"title2":"The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis","References":[{"title3":". . (Accessed 5 April 2020)."},{"title3":"The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application"},{"title3":"Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association"},{"title3":"Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic"},{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines"},{"title3":"Negative Risk Markers for Cardiovascular Events in the Elderly"},{"title3":"Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review"},{"title3":"Improved confidence intervals for odds ratios"},{"title3":"Basics of meta-analysis: I(2) is not an absolute measure of heterogeneity"},{"title3":"Covid-19 in Critically Ill Patients in the Seattle Region - Case Series"},{"title3":"Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit"},{"title3":"Clinical progression of patients with COVID-19 in Shanghai, China"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Kidney disease is associated with in-hospital death of patients with COVID-19"},{"title3":"The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) : China, 2020"},{"title3":"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: A retrospective study"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan"},{"title3":"Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China"},{"title3":"Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020"},{"title3":"Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Coronavirus Disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up"},{"title3":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China"},{"title3":"Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study"},{"title3":"The effects of age on clinical characteristics, hospitalization and mortality of patients with influenza-related illness at a tertiary care centre in Malaysia"},{"title3":"Is chronic obstructive pulmonary disease a risk factor for death in patients with community acquired pneumonia?"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"Organ reserve, excess metabolic capacity, and aging"},{"title3":"The X chromosome and sex-specific effects in infectious disease susceptibility"},{"title3":"Effect of smoking on gene expression profile - Overall mechanism, impact on respiratory system function, and reference to electronic cigarettes"},{"title3":"Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: A study based on single-cell transcriptome analysis"},{"title3":"Trends in smoking prevalence and implication for chronic diseases in China: Serial national cross-sectional surveys from 2003 to 2013"}]},{"title2":"The prognostic impact of malnutrition in patients with severely decompensated acute heart failure, as assessed using the Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) score","References":[]},{"title2":"Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Molecular evolution of human coronavirus genomes"},{"title3":"WHO Director-General's remarks at the media briefing on SARS-CoV-2 on 16 March 2020"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"KDIGO clinical pactice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"The immunopathogenesis of sepsis in elderly patients"}]},{"title2":"A tool to early predict severe corona virus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China","References":[]},{"title2":"Co-culture of primary rat hepatocytes with rat liver epithelial cells enhances interleukin-6-induced acute-phase protein response","References":[{"title3":"Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation"},{"title3":"The acute phase response"},{"title3":"Collagen-gel cultures of rat hepatocytes: collagen-gel sandwich and immobilization cultures"},{"title3":"Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes"},{"title3":"Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6"},{"title3":"Long-term co-cultures of adult human hepatocytes with rat liver epithelial cells: modulation of albumin secretion and accumulation of extracellular material"},{"title3":"Isolation of rat hepatocytes"},{"title3":"Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone in vitro"},{"title3":"A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates"},{"title3":"Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response"},{"title3":"Clinical and nutritional aspects of changes in acute-phase proteins during inflammation"},{"title3":"IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6"},{"title3":"IL6 and the acute phase reaction"},{"title3":"HepG2 cells predominantly express the type II interleukin 1 receptor (biochemical and molecular characterization of the IL-1 receptor)"},{"title3":"Cellular interactions promote tissue-specific function, biomatrix deposition and junctional communication of primary cultured hepatocytes"},{"title3":"Long term production of acute-phase proteins by adult rat hepatocytes co-cultured with another liver cell type in serum-free medium"},{"title3":"Long-term culture of functional hepatocytes"},{"title3":"Interleukin-6 and the acute phase response"},{"title3":"Quantification of acute phase proteins in rat serum and in the supernatants of a cultured rat hepatoma cell line and cultured primary hepatocytes by an enzyme-linked immunosorbent assay"},{"title3":"Long-term culture of HepG2 hepatoma cells as a model for liver acute phase response during chronic inflammation. Effects of interleukin-6, dexamethasone and retinoic acid"},{"title3":"Regulated de novo biosynthesis of fibrinogen in extrahepatic epithelial cells in response to inflammation"},{"title3":"Three high molecular weight protease inhibitors of rat plasma. Isolation, characterization, and acute phase changes"},{"title3":"Cooperation of Ito cells and hepatocytes in the deposition of an extracellular matrix in vitro"},{"title3":"Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines"},{"title3":"Albumin and fibrinogen syntheses increase while muscle protein synthesis decreases in head-injured patients"},{"title3":"IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo"},{"title3":"Cell-cell interactions are essential for maintenance of hepatocyte function in collagen gel but not on matrigel"},{"title3":"Cytokines and the hepatic acute phase response"},{"title3":"Serum-free cryopreservation of porcine hepatocytes"},{"title3":"Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: a comparison of a large cohort to the world's literature"},{"title3":"Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort"},{"title3":"Rat hepatocyte cultures and co-cultures in biotransformation studies of xenobiotics"},{"title3":"Hepatocyte cultures in drug metabolism and toxicological research and testing"},{"title3":"Characterization and functional studies on rat liver fat-storing cell line and freshly isolated hepatocyte coculture system"},{"title3":"Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism"},{"title3":"Differentiation of neonatal rat epithelial cells from biliary origin into immature hepatic cells by sequential exposure to hepatogenic cytokines and growth factors reflecting liver development"},{"title3":"Cryopreservation of isolated primary rat hepatocytes: enhanced survival and long-term hepatospecific function"},{"title3":"Expression of alpha2-macroglobulin by the interaction between hepatocytes and endothelial cells in coculture"},{"title3":"Effects of acidosis on acute phase protein metabolism in liver cells"},{"title3":"Rat hepatocyte cultures:conventional monolayer cultures and cocultures with rat liver epithelial cells"},{"title3":"Regulation of angiogenin expression in human HepG2 hepatoma cells by mediators of the acute-phase response"},{"title3":"Primary hepatocyte culture in collagen gel mixture and collagen sandwich"},{"title3":"Different proliferative potential of rat and pig hepatocytes in pure primary culture and coculture"},{"title3":"Hepatocyte function in sepsis: Kupffer cells mediate a biphasic protein synthesis response in hepatocytes after exposure to endotoxin or killed Escherichia coli"},{"title3":"Further characterization of Kupffer cell/macrophage-mediated alterations in hepatocyte protein synthesis"}]},{"title2":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus","References":[]},{"title2":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases"},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print February 24, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2648."},{"title3":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print February 28, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032."},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"Severe acute respiratory syndrome: clinical and laboratory manifestations"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"SARS immunity and vaccination"},{"title3":"Prevalence, risk factors, and management of asthma in China: a national cross-sectional study"},{"title3":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [published online ahead of print February 19, 2020]. Allergy. https://doi.org/10.1111/all.14238."},{"title3":"An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011"},{"title3":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Wu C, Chen X, Cai Y, Xia Ja, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [published online ahead of print March 13, 2020]. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994."},{"title3":"Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis [published online ahead of print March 26, 2020]. Eur Respir J. https://doi.org/10.1183/13993003.00547-2020."},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published online ahead of print February 24, 2020]. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30079-5."},{"title3":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [published online ahead of print March 18, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19 [published online ahead of print February 27, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2783."},{"title3":"Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? [published online ahead of print February 22, 2020] Int J Epidemiol. https://doi.org/10.1093/ije/dyaa033."}]},{"title2":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan","References":[]},{"title2":"Lactate dehydrogenase, a risk factor of severe COVID-19 patients","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in wuhan, China."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"National Health Commission of the People's Republic of China home page."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, China: a descriptive study."},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients."},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China."},{"title3":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China."},{"title3":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths."},{"title3":"Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: interplay between hematologic and solid neoplastic clones and their microenvironments."},{"title3":"Lactic acid downregulates viral MicroRNA to promote epstein-barr virus-immortalized B lymphoblastic cell adhesion and growth."},{"title3":"Pneumocystis infection in humans: diagnosis and treatment."},{"title3":"HIV-associated pneumocystis pneumonia."},{"title3":"2009 pandemic influenza a (H1N1): clinical and laboratory characteristics in pediatric and adult patients and in patients with pulmonary involvement."},{"title3":"A unique case of human zika virus infection in association with severe liver injury and coagulation disorders."},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses."},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding."},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis."},{"title3":"Clinical characteristics and prognosis of community acquired pneumonia in autoimmune disease induced immunocompromised host: A retrospective observational study."},{"title3":"Lactate dehydrogenase (LDH) isoenzymes and proliferative activity of lymphoid cells:an immunocytochemical study."},{"title3":"Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism."},{"title3":"Use of LDH and autoimmune side effects to predict response to ipilimumab treatment."},{"title3":"Inhibition of lactate dehydrogenase a suppresses inflammatory response in RAW 264.7 macrophages."},{"title3":"LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity."},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome."},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV."},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the american thoracic society and infectious diseases society of america."}]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice","References":[{"title3":"Alveolar macrophage in the driver's seat."},{"title3":"Regulation of immunological homeostasis in the respiratory tract."},{"title3":"Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages."},{"title3":"Alveolar macrophages. IV. Interspecies differences in activity in proliferating lymphocyte cultures."},{"title3":"Modulation of dendritic cell trafficking to and from the airways."},{"title3":"Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages."},{"title3":"MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations."},{"title3":"Regulation of T-cell function in lung tissue by pulmonary alveolar macrophages."},{"title3":"Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice."},{"title3":"Sequestration of inhaled particulate antigens by lung phagocytes. A mechanism for the effective inhibition of pulmonary cell-mediated immunity."},{"title3":"Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus."},{"title3":"Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection."},{"title3":"Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection."},{"title3":"Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression."},{"title3":"CD8+ T cells clear influenza virus by perforin or Fas-dependent processes."},{"title3":"Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs."},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome."},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome."},{"title3":"Severe acute respiratory syndrome-associated coronavirus in lung tissue."},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells."},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis."},{"title3":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells."},{"title3":"Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells."},{"title3":"SARS-coronavirus replication in human peripheral monocytes/macrophages."},{"title3":"Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection."},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells."},{"title3":"SARS coronavirus and innate immunity."},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice."},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice."},{"title3":"Transient suppression of macrophage functions by liposome-encapsulated drugs."},{"title3":"Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications."},{"title3":"Differential response of respiratory dendritic cell subsets to influenza virus infection."},{"title3":"Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli."},{"title3":"The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen."},{"title3":"Respiratory syncytial virus activates innate immunity through Toll-like receptor 2."},{"title3":"Characterization of the activation-associated isoform of CD43 on murine T lymphocytes."},{"title3":"Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells."},{"title3":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein."},{"title3":"Identification of synthetic vaccine candidates against SARS CoV infection."},{"title3":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses."},{"title3":"The mononuclear phagocyte system revisited."},{"title3":"A critical function for CD200 in lung immune homeostasis and the severity of influenza infection."},{"title3":"Suppression of T-cell activation by pulmonary alveolar macrophages: dissociation of effects on TcR, IL-2R expression, and proliferation."},{"title3":"Toll-like receptors: linking innate and adaptive immunity."},{"title3":"Toll-like receptor control of the adaptive immune responses."},{"title3":"Toll-like receptor function and signaling."},{"title3":"CpG-DNA protects against a lethal orthopoxvirus infection in a murine model."},{"title3":"Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA."},{"title3":"Clinical investigations of Toll-like receptor agonists."},{"title3":"Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling."},{"title3":"Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection."},{"title3":"Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming."},{"title3":"Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells."},{"title3":"Preferential infection of mature dendritic cells by mouse hepatitis virus strain JHM."},{"title3":"Initial viral load and the outcomes of SARS."},{"title3":"Viral loads in clinical specimens and SARS manifestations."},{"title3":"Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections."},{"title3":"Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema."},{"title3":"Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway."},{"title3":"Alveolar macrophages regulate the induction of primary cytotoxic T-lymphocyte responses during influenza virus infection."},{"title3":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice."},{"title3":"Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)."},{"title3":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4."},{"title3":"The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells."},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury."},{"title3":"Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications."},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV."},{"title3":"Inflammasome recognition of influenza virus is essential for adaptive immune responses."},{"title3":"The influenza virus NS1 protein: inhibitor of innate and adaptive immunity."},{"title3":"Inhibition of Toll Like Receptor immune responses by microbial pathogens."},{"title3":"Cutting edge: rapid in vivo killing by memory CD8 T cells."},{"title3":"Alveolar macrophages. I. A simple technique for the preparation of high numbers of viable alveolar macrophages from small laboratory animals."},{"title3":"Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor."}]},{"title2":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","References":[{"title3":"Masters PS, Perlman, S (2013) Coronaviridae. In: Knipe DM, Howley P (eds) Fields Virology. Lippincott Williams and Wilkins, Philadelphia, PA, pp 825-858"},{"title3":"Coronavirus host range expansion and Middle East respiratory syndrome coronavirus emergence: biochemical mechanisms and evolutionary perspectives"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Coronavirus-associated pneumonia in previously healthy children"},{"title3":"Clinical disease in children associated with newly described coronavirus subtypes"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"van Boheemen S et al (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3(6)"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"WHO Cumulative number of reported probable cases of SARS. In: 2003"},{"title3":"http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_20140613.pdf WUoM-CTfAtHaIRfA-RGLaoMAf"},{"title3":"WHO: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical and laboratory findings of SARS in Singapore"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"SARS: clinical virology and pathogenesis"},{"title3":"The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"van den Brand JM et al (2014) The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 151(1):83-112"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections"},{"title3":"Age-dependent dysregulation of innate immunity"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Chu H et al (2015) Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis 213(6):904-14"},{"title3":"Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Animal models of Middle East respiratory syndrome coronavirus infection"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Cockrell A et al (2016) A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nature Microbiology 2:16226"},{"title3":"Li K et al (2017) Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proceedings of the National Academy of Sciences 114(15):E3119-E3128"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Interaction of SARS and MERS coronaviruses with the antiviral interferon response"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling"},{"title3":"Interferon and cytokine responses to SARS-coronavirus infection"},{"title3":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Fehr AR et al (2016) The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. mBio 7(6):e01721-16"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain"},{"title3":"Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Initial viral load and the outcomes of SARS"},{"title3":"Proliferative growth of SARS coronavirus in Vero E6 cells"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand"},{"title3":"Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia"},{"title3":"Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Not so fast: adaptive suppression of innate immunity"},{"title3":"Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection"},{"title3":"Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Reghunathan R et al (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunology 6:2"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Zumla A et al (2016) Coronaviruses:drug discovery and therapeutic options. Nat Rev Drug Discov 15(5):327-47"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"IFN-lambda resolves inflammation via suppression of neutrophil infiltration and IL-1beta production"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection"},{"title3":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection"},{"title3":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus"},{"title3":"Silencing of CCR2 in myocarditis"},{"title3":"Therapeutic siRNA silencing in inflammatory monocytes in mice"},{"title3":"Immunomodulatory therapy for severe influenza"},{"title3":"The effect of inhibition of PP1 and TNFalpha signaling on pathogenesis of SARS coronavirus"}]},{"title2":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","References":[{"title3":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study"}]},{"title2":"Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"},{"title3":"Potential antiviral therapeutics for 2019 novel coronavirus"},{"title3":"Which lessons shall we learn from the 2019 novel coronavirus outbreak?"},{"title3":"The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019"},{"title3":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications of virus origins and receptor binding"},{"title3":"Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses"},{"title3":"Potentbinding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific humanmonoclonal antibody"},{"title3":"The effect of SARS coronavirus on blood system:its clinical findings and the pathophysiologichypothesis"},{"title3":"Platelets in inflammation and infection"},{"title3":"Relationship between generalized epileptic seizure and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and neutrophil mediated inflammation"},{"title3":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)"},{"title3":"SARS-CoV proteins decrease levels and activity of human ENaC via activation of distinct PKC isoforms"},{"title3":"In vitro large scale production of megakaryocytes to functional platelets from human hematopoietic stem cells"},{"title3":"Cytokine control of megakaryopoiesis"},{"title3":"Clinical characteristics of 138 hospitalized patients With 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia"},{"title3":"Inactivation of three emerging viruses severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light"},{"title3":"Proteomic analysis reveals platelet factor 4 and beta-thromboglobulin as prognostic markers in severe acute respiratory syndrome"},{"title3":"Analysis of the level of selected parameters of inflammation,circulating immune complexes,and related indicators (neutrophil/lymphocyte, platelet/lymphocyte, CRP/CIC) in patients with obstructive diseases"},{"title3":"Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J]"},{"title3":"Inflammatory impact of IFN-gamma in CD8+T cellmediated lung injury is mediated by both Stat1-dependent and-independent pathways"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"Host response to influenza virus: protection versus immunopathology"},{"title3":"Cancer patients in SARS-CoV-2 infection:a nationwide analysis in China"},{"title3":"Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"The dual role of platelet-innate immune cell interactions in thrombo-inflammation"},{"title3":"Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia"},{"title3":"Emerging novel Coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"}]},{"title2":"Quantification of NETs formation in neutrophil and its correlation with the severity of sepsis and organ dysfunction","References":[]},{"title2":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of middle east respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV-Summary of Current Situation"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Evaluation of pigtail macaques as a model for the effects of copper intrauterine devices on HIV infection"},{"title3":"Pathology and pathogenesis of fatal Bordetella pertussis infection in infants"},{"title3":"Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus"},{"title3":"ClustalW and ClustalX version 2 (2007)"},{"title3":"MRBAYES: Bayesian inference of phylogenetic trees"},{"title3":"Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus"},{"title3":"Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs"},{"title3":"Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS"},{"title3":"Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells"},{"title3":"Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis"},{"title3":"Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected"}]},{"title2":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity","References":[{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV), &lt; http://www.who.int/emergencies/mers-cov/en/ &gt;(2015) (Date of acess:31/03/2016)."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Transmission of MERS-coronavirus in household contacts"},{"title3":"MERS-CoV outbreak in Jeddah-a link to health care facilities"},{"title3":"Korea Centers for Disease, C. &amp; Prevention. Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 6, 269-278, doi: 10.1016/j.phrp.2015.08.006 (2015)."},{"title3":"South Korean MERS outbreak spotlights lack of research"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Association of Higher MERS-CoV Virus Load with Severe Disease and Death, Saudi Arabia, 2014"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Middle East Respiratory Syndrome in 3 Persons, South Korea, 2015"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Viral shedding and antibody response in 37 patients with MERS-coronavirus infection"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome"},{"title3":"Possible central nervous system infection by SARS coronavirus"},{"title3":"New insights into the regulation of T cells by gamma(c) family cytokines"},{"title3":"The signaling role of CD40 ligand in platelet biology and in platelet component transfusion"},{"title3":"Effects of epidermal growth factor on atrophic enteritis in piglets induced by experimental porcine epidemic diarrhoea virus"},{"title3":"Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome"},{"title3":"Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Expression of IL-15 in inflammatory pulmonary diseases"},{"title3":"TSLP promotes influenza-specific CD8 + T-cell responses by augmenting local inflammatory dendritic cell function"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon"},{"title3":"TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo"},{"title3":"Inflammatory mechanisms in the lung"},{"title3":"Assessing prognosis and predicting patient outcomes in community-acquired pneumonia"},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia"},{"title3":"Sputum Autoantibodies in Patients With Established Rheumatoid Arthritis and Subjects at Risk of Future Clinically Apparent Disease"}]}]},{"title1":"A prediction model of outcome of SARS-CoV-2 pneumonia based on laboratory findings","References":[{"title2":"Identification of a novel coronavirus in patients with severe acuterespiratory syndrome","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"The novel coronavirus originating in Wuhan, China: challenges for global health governance","References":[]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases - Wuhan, China 2019-2020"},{"title3":"A familiar cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"China coronavirus: WHO declares international emergency as death toll exceeds 200"},{"title3":"Severe acute respiratory syndrome: clinical and laboratory manifestations"},{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"The novel coronavirus in Wuhan, China: challenges for global health governance"},{"title3":"The extent of transmission of novel coronavirus in Wuhan, China, 2020"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing"},{"title3":"CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Emerging coronavirus 2019-nCoV pneumonia"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"Chest imaging appearance of COVID-19 infection"},{"title3":"The many faces of COVID-19: spectrum of imaging manifestations"},{"title3":"Longitudinal CT findings in COVID-19 pneumonia: case presenting organizing pneumonia pattern"},{"title3":"Spectrum of chest CT findings in a familial cluster of COVID-19 infection"},{"title3":"COVID-19 infection presenting with CT halo sign"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"China's Hubei reports jump in new cases of COVID-19 after diagnosis criteria revision"}]},{"title2":"Sensitivity of chest CT for COVID-19: comparison to RT-PCR","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing"},{"title3":"Emerging Coronavirus 2019-nCoV Pneumonia"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"}]},{"title2":"General Office of the National Health Commission of China. Diagnosis and treatment protocol for 2019-nCoV. 5th ed. Beijing, China: National Health Commission of China (2020).","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Next-generation radiogenomics sequencing for prediction of EGFR and KRAS mutation status in NSCLC patients using multimodal imaging and machine learning algorithms","References":[]},{"title2":"Prediction model of aryl hydrocarbon receptor activation by a novel QSAR approach, deepSnap-deep learning","References":[{"title3":"Toxicant-associated steatohepatitis in vinyl chloride workers"},{"title3":"Putative mechanisms of environmental chemical-induced steatosis"},{"title3":"Identification of environmental chemicals-associated with the development of toxicant-associated fatty liver disease in rodents"},{"title3":"Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways"},{"title3":"Integration of metabolomics and transcriptomics reveals short-chain chlorinated paraffin-induced hepatotoxicity in male Sprague-Dawley rat"},{"title3":"Exposure to Persistent Organic Pollutants (POPs) and Their Relationship to Hepatic Fat and Insulin Insensitivity among Asian Indian Immigrants in the United States"},{"title3":"Interventions to Address Environmental Metabolism-Disrupting Chemicals: Changing the Narrative to Empower Action to Restore Metabolic Health"},{"title3":"Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States"},{"title3":"Managing the challenge of drug-induced liver injury: A roadmap for the development and deployment of preclinical predictive models"},{"title3":"Idiosyncratic drug hepatotoxicity"},{"title3":"Drug-induced liver injury severity and toxicity (DILIst): Binary classification of 1279 drugs by human hepatotoxicity"},{"title3":"Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses"},{"title3":"Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals"},{"title3":"AhR sensing of bacterial pigments regulates antibacterial defence"},{"title3":"Functions of aryl hydrocarbon receptor (AHR) and CD38 in NAD metabolism and nonalcoholic steatohepatitis (NASH)"},{"title3":"QSAR modelling of a large imbalanced aryl hydrocarbon activation dataset by rational and random sampling and screening of 80,086 REACH pre-registered and/or registered substances"},{"title3":"Role of the Aryl Hydrocarbon Receptor in Environmentally Induced Skin Aging and Skin Carcinogenesis"},{"title3":"Air particulate matter induced oxidative stress and inflammation in cardiovascular disease and atherosclerosis: The role of Nrf2 and AhR-mediated pathways"},{"title3":"Structural hierarchy controlling dimerization and target DNA recognition in the AHR transcriptional complex"},{"title3":"The aryl hydrocarbon receptor repressor:More than a simple feedback inhibitor of AhR signaling: Clues for its role in inflammation and cancer"},{"title3":"AhR signaling pathways and regulatory functions"},{"title3":"Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis"},{"title3":"Chemical activation of estrogen and aryl hydrocarbon receptor signaling pathways and their interaction in toxicology and metabolism"},{"title3":"Beyond the Aryl Hydrocarbon Receptor: Pathway Interactions in the Hepatotoxicity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Related Compounds"},{"title3":"The aryl hydrocarbon receptor in the crossroad of signalling networks with therapeutic value"},{"title3":"Constitutive Activation of the Human Aryl Hydrocarbon Receptor in Mice Promotes Hepatocarcinogenesis Independent of Its Coactivator Gadd45b"},{"title3":"Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors"},{"title3":"Aryl Hydrocarbon Receptor Promotes Liver Polyploidization and Inhibits PI3K, ERK, and Wnt/beta-Catenin Signaling"},{"title3":"Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates"},{"title3":"New thiobarbituric acid scaffold-based small molecules: Synthesis, cytotoxicity, 2D-QSAR, pharmacophore modelling and in-silico ADME screening"},{"title3":"QSAR modeling of Daphnia magna and fish toxicities of biocides using 2D descriptors"},{"title3":"In silico toxicity evaluation of dioxins using structure-activity relationship (SAR) and two-dimensional quantitative structure-activity relationship (2D-QSAR)"},{"title3":"Quantitative Structure-Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells"},{"title3":"Descriptors and their selection methods in QSAR analysis: Paradigm for drug design"},{"title3":"Experimental Errors in QSAR Modeling Sets: What We Can Do and What We Cannot Do"},{"title3":"Building of Robust and Interpretable QSAR Classification Models by Means of the Rivality Index"},{"title3":"A Machine Learning Approach for the Discovery of Ligand-Specific Functional Mechanisms of GPCRs"},{"title3":"Deep-learning: Investigating deep neural networks hyper-parameters and comparison of performance to shallow methods for modeling bioactivity data"},{"title3":"Beyond the hype: Deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set"},{"title3":"Machine Learning Methods in Computational Toxicology"},{"title3":"Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction"},{"title3":"Validation study of QSAR/DNN models using the competition datasets"},{"title3":"Optimal selection of molecular descriptors for antimicrobial peptides classification: An evolutionary feature weighting approach"},{"title3":"Analysis and Comparison of Vector Space and Metric Space Representations in QSAR Modeling"},{"title3":"Improving Recognition of Antimicrobial Peptides and Target Selectivity through Machine Learning and Genetic Programming"},{"title3":"Quantitative structure-activity relationship analysis using deep learning based on a novel molecular image input technique"},{"title3":"Optimization of a Deep-Learning Method Based on the Classification of Images Generated by Parameterized Deep Snap a Novel Molecular-Image-Input Technique for Quantitative Structure-Activity Relationship (QSAR) Analysis"},{"title3":"Prediction Model with High-Performance Constitutive Androstane Receptor (CAR) Using DeepSnap-Deep Learning Approach from the Tox21 10K Compound Library"},{"title3":"DeepSnap-Deep Learning Approach Predicts Progesterone Receptor Antagonist Activity with High Performance"},{"title3":"A systematic study of the class imbalance problem in convolutional neural networks"},{"title3":"Discovery of Small-Molecule Activators for Glucose-6-Phosphate Dehydrogenase (G6PD) Using Machine Learning Approaches"},{"title3":"Improving the accuracy of Density Functional Theory (DFT) calculation for homolysis bond dissociation energies of Y-NO bond: Generalized regression neural network based on grey relational analysis and principal component analysis"},{"title3":"Possible involvement of the competition for the transcriptional coactivator glucocorticoid receptor-interacting protein 1 in the inflammatory signal-dependent suppression of PXR-mediated CYP3A induction in vitro"},{"title3":"CORINA Classic:High-Quality 3D Molecular Models"},{"title3":"In Silico Prediction of Chemical-Induced Hepatocellular Hypertrophy Using Molecular Descriptors"},{"title3":"IMAGENET Large Scale Visual Recognition Challenge 2012 (ILSVRC2012)"},{"title3":"IMAGENET"},{"title3":"REMODEL: Rethinking Deep CNN Models to Detect and Count on a NeuroSynaptic System"},{"title3":"Study on the Classification Performance of Underwater Sonar Image Classification Based on Convolutional Neural Networks for Detecting a Submerged Human Body"},{"title3":"BrainMRNet: Brain tumor detection using magnetic resonance images with a novel convolutional neural network model"},{"title3":"The development of food image detection and recognition model of Korean food for mobile dietary management"},{"title3":"Application of convolutional neural networks for classification of adult mosquitoes in the field"},{"title3":"Glioma Grading on Conventional MR Images: A Deep Learning Study With Transfer Learning"},{"title3":"Going Deeper with Convolutions"},{"title3":"CNN-based diagnosis models for canine ulcerative keratitis"},{"title3":"Mordred: A molecular descriptor calculator"},{"title3":"Mordred-Descriptor/Mordred"},{"title3":"Random-Forest-Classifier"},{"title3":"Xgboost/Python-Package"},{"title3":"Microsoft/Lightgbm"},{"title3":"Catboost/Catboost"},{"title3":"Scavager: A Versatile Postsearch Validation Algorithm for Shotgun Proteomics Based on Gradient Boosting"},{"title3":"Obesity cutoff values in Korean men with motor complete spinal cord injury: Body mass index and waist circumference"},{"title3":"HbA1c Cutoff Point of 5.9% Better Identifies High Risk of Progression to Diabetes among Chinese Adults: Results from a Retrospective Cohort Study"},{"title3":"Application of in-line near infrared spectroscopy and multivariate batch modeling for process monitoring in fluid bed granulation"},{"title3":"Batch-to-batch quality consistency evaluation of botanical drug products using multivariate statistical analysis of the chromatographic fingerprint"},{"title3":"Monitoring batch-to-batch reproducibility using direct analysis in real time mass spectrometry and multivariate analysis: A case study on precipitation"},{"title3":"Comparability of higher order structure in proteins: Chemometric analysis of second-derivative amide I Fourier transform infrared spectra"},{"title3":"A Wilcoxon-Mann-Whitney type test for infinite dimensional data"},{"title3":"A Robust Method for Shift Detection in Time Series"},{"title3":"The Mann-Whitney U-statistic for alpha-dependent sequences"}]},{"title2":"Machine learning algorithms applied to a prediction of personal overall thermal comfort using skin temperatures and occupants' heating behavior","References":[]},{"title2":"Nomogram based on shear-wave elastography radiomics can improve preoperative cervical lymph node staging for papillary thyroid carcinoma","References":[]},{"title2":"T2-weighted image-based radiomics signature for discriminating between seminomas and nonseminoma","References":[{"title3":"Testicular cancer"},{"title3":"Testicular germ cell tumor: a comprehensive review"},{"title3":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"},{"title3":"Apparent diffusion coefficient values and dynamic contrast enhancement patterns in differentiating seminomas from non-seminomatous testicular neoplasms"},{"title3":"Guidelines on testicular cancer: 2015 update"},{"title3":"Pure seminoma: a review and update"},{"title3":"Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"},{"title3":"MRI of testicular malignancies"},{"title3":"MRI in the histologic characterization of testicular neoplasms"},{"title3":"Is there any difference between seminomas and nonseminomatous germ cell tumors on shear wave elastography? A preliminary study"},{"title3":"Characterization of testicular germ cell tumors: whole-lesion histogram analysis of the apparent diffusion coefficient at 3T"},{"title3":"Sonography of the scrotum"},{"title3":"MRI of the scrotum: recommendations of the ESUR scrotal and penile imaging working group"},{"title3":"Radiomics: extracting more information from medical images using advanced feature analysis"},{"title3":"Radiomics: the bridge between medical imaging and personalized medicine"},{"title3":"Radiomics: images are more than pictures, they are data"},{"title3":"Decoding tumour phenotype by non-invasive imaging using a quantitative radiomics approach"},{"title3":"Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer"},{"title3":"Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer"},{"title3":"Radiomics analysis of gadoxetic acid-enhanced MRI for staging liver fibrosis"},{"title3":"Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer"},{"title3":"Testicular cancer"},{"title3":"Computational radiomics system to decode the radiographic phenotype"},{"title3":"Associations of radiomic data extracted from static and respiratory-gated CT scans with disease recurrence in lung cancer patients treated with SBRT"},{"title3":"mRMRe: an R package for parallelized mRMR ensemble feature selection"},{"title3":"Selection of important variables and determination of functional form for continuous predictors in multivariable model building"},{"title3":"Applying radiomics to predict pathology of postchemotherapy retroperitoneal nodal masses in germ cell tumors"},{"title3":"A new approach to predict progression-free survival in stage IV EGFR-mutant NSCLC patients with EGFR-TKI therapy"},{"title3":"Prognostic value of deep learning PET/CT-based radiomics: potential role for future individual induction chemotherapy in advanced nasopharyngeal carcinoma"},{"title3":"Multi-parametric MRI-based radiomics signature for discriminating between clinically significant and insignificant prostate cancer: cross-validation of a machine learning method"},{"title3":"Readout-segmented echo-planar imaging in diffusion-weighted mr imaging in breast cancer: comparison with single-shot echo-planar imaging in image quality"},{"title3":"Reduced field of view echo-planar imaging diffusion tensor MRI for pediatric spinal tumors"},{"title3":"Pilot study of rapid MR pancreas screening for patients with BRCA mutation"},{"title3":"Suspicious breast lesions: assessment of 3D Doppler US indexes for classification in a test population and fourfold cross-validation scheme"},{"title3":"Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study"}]},{"title2":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","References":[]},{"title2":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","References":[{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS-CoV: where are we now?"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry"},{"title3":"Emerging respiratory viral infections: MERS-CoV and influenza"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Middle East respiratory syndrome coronavirus &quot;MERS-CoV&quot;: current knowledge gaps"},{"title3":"2015 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"The epidemiology of MERS-CoV"},{"title3":"Emerging viral respiratory tract infections-environmental risk factors and transmission"},{"title3":"Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"A. Mailles, K. Blanckaert, P. Chaud, S. van der Werf, B. Lina, V. Caro, et al., First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 18 (2013)."},{"title3":"J. Premila Devi, W. Noraini, R. Norhayati, C. Chee Kheong, A.S. Badrul, S. Zainah, et al., Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 19 (2014)."},{"title3":"Tracing airline travelers for a public health investigation: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, 2014"},{"title3":"T. Briese, N. Mishra, K. Jain, I.S. Zalmout, O.J. Jabado, W.B. Karesh, et al., Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia, mBio 5 (2014) e01146-e01214."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction"},{"title3":"MERS-CoV geography and ecology in the Middle East: analyses of reported camel exposures and a preliminary risk map"},{"title3":"Dromedary MERS-CoV replicates in human respiratory tissues"},{"title3":"Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"Infection control and MERS-CoV in health-care workers"},{"title3":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East Respiratory Syndrome-Coronavirus from the central MERS-CoV designated hospital"},{"title3":"Acute management and long-term survival among subjects with severe Middle East Respiratory Syndrome coronavirus Pneumonia and Ards"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data"},{"title3":"Guidelines for the laboratory diagnosis of Middle East respiratory syndrome coronavirus in Korea"},{"title3":"Cytometric bead array: a multiplexed assay platform with applications in various areas of biology"},{"title3":"Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts)"},{"title3":"Safety, tolerability, and immunogenicity of interferons"},{"title3":"A tale of two cytokines: IL-17 and IL-22 in asthma and infection"},{"title3":"Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis"},{"title3":"Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions"},{"title3":"Infection-induced IL-10 and JAK-STAT: a review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes"},{"title3":"MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Virus multiplicity of infection affects type I interferon subtype induction profiles and interferon-stimulated genes"},{"title3":"Interferon-stimulated genes response in endothelial cells following Hantaan virus infection"},{"title3":"Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection"},{"title3":"T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates"},{"title3":"Coronavirus virulence genes with main focus on SARS-CoV envelope gene"},{"title3":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells"},{"title3":"L. Josset, V.D. Menachery, L.E. Gralinski, S. Agnihothram, P. Sova, V.S. Carter, et al., Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus, mBio 4 (2013) e00165-e00213."},{"title3":"IL-17 cytokines in immunity and inflammation"},{"title3":"IL-10, T cell exhaustion and viral persistence"},{"title3":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction"},{"title3":"The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes"},{"title3":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins"},{"title3":"Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function"},{"title3":"Hepatitis C virus targets the interferon-alpha JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes"},{"title3":"Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling"},{"title3":"Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells"},{"title3":"IL-15-PI3K-AKT-mTOR: a critical pathway in the life journey of natural killer cells"},{"title3":"TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals"},{"title3":"The IL-12 family of cytokines in infection, inflammation and autoimmune disorders"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Stimulation of IRF-7 gene expression by tumor necrosis factor alpha requirement for NFkappaB transcription factor and gene accessibility"}]},{"title2":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","References":[{"title3":"Masters PS, Perlman, S (2013) Coronaviridae. In: Knipe DM, Howley P (eds) Fields Virology. Lippincott Williams and Wilkins, Philadelphia, PA, pp 825-858"},{"title3":"Coronavirus host range expansion and Middle East respiratory syndrome coronavirus emergence: biochemical mechanisms and evolutionary perspectives"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Coronavirus-associated pneumonia in previously healthy children"},{"title3":"Clinical disease in children associated with newly described coronavirus subtypes"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"van Boheemen S et al (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3(6)"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"WHO Cumulative number of reported probable cases of SARS. In: 2003"},{"title3":"http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_20140613.pdf WUoM-CTfAtHaIRfA-RGLaoMAf"},{"title3":"WHO: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical and laboratory findings of SARS in Singapore"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"SARS: clinical virology and pathogenesis"},{"title3":"The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"van den Brand JM et al (2014) The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 151(1):83-112"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections"},{"title3":"Age-dependent dysregulation of innate immunity"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Chu H et al (2015) Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis 213(6):904-14"},{"title3":"Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Animal models of Middle East respiratory syndrome coronavirus infection"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Cockrell A et al (2016) A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nature Microbiology 2:16226"},{"title3":"Li K et al (2017) Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proceedings of the National Academy of Sciences 114(15):E3119-E3128"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Interaction of SARS and MERS coronaviruses with the antiviral interferon response"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling"},{"title3":"Interferon and cytokine responses to SARS-coronavirus infection"},{"title3":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Fehr AR et al (2016) The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. mBio 7(6):e01721-16"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain"},{"title3":"Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Initial viral load and the outcomes of SARS"},{"title3":"Proliferative growth of SARS coronavirus in Vero E6 cells"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand"},{"title3":"Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia"},{"title3":"Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Not so fast: adaptive suppression of innate immunity"},{"title3":"Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection"},{"title3":"Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Reghunathan R et al (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunology 6:2"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Zumla A et al (2016) Coronaviruses:drug discovery and therapeutic options. Nat Rev Drug Discov 15(5):327-47"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"IFN-lambda resolves inflammation via suppression of neutrophil infiltration and IL-1beta production"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection"},{"title3":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection"},{"title3":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus"},{"title3":"Silencing of CCR2 in myocarditis"},{"title3":"Therapeutic siRNA silencing in inflammatory monocytes in mice"},{"title3":"Immunomodulatory therapy for severe influenza"},{"title3":"The effect of inhibition of PP1 and TNFalpha signaling on pathogenesis of SARS coronavirus"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics of 2019 novel coronavirus infection in China","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019nCoV epidemic threat of novel coronaviruses to global health  the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (SARS-CoV-2), December 2019 to January 2020"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [published online ahead of print, 2020 Jan 24]"},{"title3":"The latest situation of new coronavirus pneumonia as of 24:00 on February"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (SARS-CoV-2)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Pathogenicity and transmissibility of SARS-CoV-2-A quick overview and comparison with other emerging viruses"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Notice on issuing a new coronavirus infected pneumonia diagnosis and treatment plan (Trial Version 5)"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan"},{"title3":"early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"30 January 2020 pneumonia epidemic situation of C SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"4 February 2020 pneumonia epidemic situation of SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronaviruspneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus"},{"title3":"CT imaging features of 2019 novel coronavirus (SARS-CoV-2)"},{"title3":"Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease"},{"title3":"Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients"},{"title3":"Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China"},{"title3":"Detection of Covid-19 in children in early January 2020 in Wuhan, China"},{"title3":"National Health Commission. Notice on issuing a nw coronary virus pneumonia diagnosis and treatment plan (Trial Version 7)"}]},{"title2":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","References":[{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score"},{"title3":"Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure"}]},{"title2":"Liver injury during highly pathogenic human coronavirus infections","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Researchers scramble to understand camel connection to MERS"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Hematological and biochemical factors predicting SARS fatality in Taiwan"},{"title3":"Dynamic changes of liver function and myocardial enzyme in 259 patients with severe acute respiratory syndrome"},{"title3":"Clinical characteristics and mechanism of liver function injury in 250 patients with severe acute respiratory syndrome"},{"title3":"Prevention and treatment of liver injury in SARS patients-222 cases analysis"},{"title3":"Effect of SARS associated coronavirus on peripheral blood picture and liver function"},{"title3":"The clinic characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome"},{"title3":"Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome"},{"title3":"Study of the relationship SARS and hepatitis virus B"},{"title3":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients"},{"title3":"Clinical feature of liver injury in patients with severe acute respiratory syndrome"},{"title3":"Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome"},{"title3":"The dynamic change of liver injury in patients with severe acute respiratory syndrome"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Ultrastructure pathology of all organs in severe acute respiratory syndrome"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway"},{"title3":"Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia"},{"title3":"Clinical and laboratory findings of Middle East respiratory syndrome coronavirus infection"},{"title3":"Critically Ill patients with the Middle East respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"The multifunctional or moonlighting protein CD26/DPPIV"},{"title3":"Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome-coronavirus"},{"title3":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile"},{"title3":"Coronavirus disease"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"COVID-19 in a Designated Infectious Diseases HospitalOutside Hubei Province, China"},{"title3":"Clinical features of COVID-19-related liver damage"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of 82 death cases with COVID-19"},{"title3":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-1 coronavirus receptor2 ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection"},{"title3":"Cholangiocyte pathobiology"},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Diagnosis and Treatment of Coronavirus disease 2019 (Trial Version 7)"},{"title3":"Guidelines for the management of drug-induced liver injury"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Isolation and characterization of 2019-nCoV-like coronavirus from Malayan pangolins"}]},{"title2":"Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation","References":[]},{"title2":"The clinical and chest CT features associated with severe and critical COVID-19 pneumonia","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses - a statement of the coronavirus study group"},{"title3":"World experts and funders set priorities for COVID-19 research"},{"title3":"Novel coronavirus in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Diagnosis and treatment protocols of pneumonia caused by a novel coronavirus (trial version 5)"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity"},{"title3":"Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Radiographic and CT features of viral pneumonia"},{"title3":"Imaging of pulmonary viral pneumonia"}]},{"title2":"Complement activation in human sepsis is related to sepsis-induced disseminated intravascular coagulation","References":[]},{"title2":"A new feature selection method based on symmetrical uncertainty and interaction gain","References":[]},{"title2":"Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer","References":[]},{"title2":"Selection of important variables and determination of functional form for continuous predictors in multivariable model building","References":[]}]},{"title1":"Clinical features of COVID-19 mortality: development and validation of a clinical prediction model","References":[{"title2":"An interactive web-based dashboard to track COVID-19 in real time","References":[{"title3":"WHO statement regarding cluster of pneumonia cases in Wuhan, China"},{"title3":"Coronavirus disease 2019 (COVID-19) situation reports"},{"title3":"Tracking the epidemic"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"Health effects of second-hand smoke. Atlanta GA: US Centers for Disease Control and Prevention","References":[]},{"title2":"Strategies for handling missing data in electronic health record derived data","References":[{"title3":"Launching HITECH"},{"title3":"Use of electronic medical records differs by specialty and office settings"},{"title3":"The effect of electronic prescribing on medication errors and adverse drug events: a systematic review"},{"title3":"The impact of computerized provider order entry on medication errors in a multispecialty group practice"},{"title3":"Electronic health records and clinical decision support systems: impact on national ambulatory care quality"},{"title3":"Electronic health record use and the quality of ambulatory care in the United States"},{"title3":"Electronic health records and quality of diabetes care"},{"title3":"Electronic health records and ambulatory quality of care"},{"title3":"A new approach to making your doctor-nurse team more productive"},{"title3":"Prevalence of multiple chronic conditions in the United States' Medicare population"},{"title3":"A method and knowledge base for automated inference of patient problems from structured data in an electronic medical record"},{"title3":"Validity of self-reported hypertension in the National Health and Nutrition Examination Survey III, 1988-1991"},{"title3":"Missing data: our view of the state of the art"},{"title3":"Inference and missing data"},{"title3":"Exploiting missing clinical data in Bayesian network modeling for predicting medical problems"},{"title3":"Handling &quot;don't know&quot; survey responses: the case of the Slovenian plebiscite"},{"title3":"A comparison of inclusive and restrictive strategies in modern missing data procedures"},{"title3":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data"},{"title3":"Multiple imputation of missing values"},{"title3":"Using the outcome for imputation of missing predictor values was preferred"},{"title3":"Multiple imputation using chained equations: Issues and guidance for practice"},{"title3":"MICE: Multivariate imputation by chained equations in R"},{"title3":"The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis"},{"title3":"American Community Survey"},{"title3":"Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes"},{"title3":"A Primer and Comparative Review of Major U.S. Mortality Databases"},{"title3":"Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis"},{"title3":"Prediction of morbidity and mortality in patients with type 2 diabetes"},{"title3":"Electronic health records: a new tool to combat chronic kidney disease?"},{"title3":"Development and validation of an electronic health record-based chronic kidney disease registry"}]},{"title2":"Gene selection for cancer classification using support vector machines","References":[]},{"title2":"Statistical comparisons of classifiers over multiple data sets","References":[]},{"title2":"Classification evaluation","References":[]},{"title2":"Calibration: the Achilles heel of predictive analytics","References":[{"title3":"Tufts PACE clinical predictive model registry: update 1990 through 2015"},{"title3":"Prognostic models in obstetrics: available, but far from applicable"},{"title3":"A calibration hierarchy for risk models was defined: from utopia to empirical data"},{"title3":"External validation of multivariable prediction models: a systematic review of methodological conduct and reporting"},{"title3":"A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models"},{"title3":"Reporting and methods in clinical prediction research: a systematic review"},{"title3":"Calibration of risk prediction models: impact on decision-analytic performance"},{"title3":"A spline-based tool to assess and visualize the calibration of multiclass risk predictions"},{"title3":"Modern modeling techniques had limited external validity in predicting mortality from traumatic brain injury"},{"title3":"Big data and predictive analytics: recalibrating expectations"},{"title3":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration"},{"title3":"A deep learning mammography-based model for improved breast cancer risk prediction"},{"title3":"Predicting the chance of live birth for women undergoing IVF: a novel pretreatment counselling tool"},{"title3":"Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2"},{"title3":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"},{"title3":"Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study"},{"title3":"External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges"},{"title3":"Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram"},{"title3":"Calibration drift in regression and machine learning models for acute kidney injury"},{"title3":"Prospective validation of the good outcome following attempted resuscitation (GO-FAR) score for in-hospital cardiac arrest prognosis"},{"title3":"Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study"},{"title3":"Comparison of two models predicting IVF success; the effect of time trends on model performance"},{"title3":"Poor performance of clinical prediction models: the harm of commonly applied methods"},{"title3":"Clinical impact of prostate specific antigen (PSA) inter-assay variability on management of prostate cancer"},{"title3":"Screening for data clustering in multicenter studies: the residual intraclass correlation"},{"title3":"Impact of predictor measurement heterogeneity across settings on performance of prediction models: a measurement error perspective"},{"title3":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass"},{"title3":"Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers"},{"title3":"Sample size for binary logistic prediction models: beyond events per variable criteria"},{"title3":"Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes"},{"title3":"Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example"},{"title3":"Van Calster B, van Smeden M, Steyerberg EW. On the variability of regression shrinkage methods for clinical prediction models: simulation study on predictive performance. arXiv. 2019; https://arxiv.org/abs/1907.11493. Accessed 10 Oct 2019."},{"title3":"Validation and updating of predictive logistic regression models: a study on sample size and shrinkage"},{"title3":"A review of statistical updating methods for clinical prediction models"},{"title3":"Dynamic prediction modeling approaches for cardiac surgery"},{"title3":"Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts"},{"title3":"External validation and extension of a diagnostic model for obstructive coronary artery disease: a cross-sectional predictive evaluation in 4888 patients of the Austrian Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Cardiovascular disease, drug therapy, and mortality in COVID-19","References":[]},{"title2":"COVID-19 in critically ill patients in the Seattle region:case series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Regional planning for extracorporeal membrane oxygenation allocation during COVID-19","References":[]},{"title2":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","References":[]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"Clinical characteristics of COVID-19 in China","References":[{"title3":"Transmission modes of COVID-19: a systematic review"},{"title3":"The role of COVID-19 in myopathy: incidence, causes, treatment, and prevention"},{"title3":"Convergent evolution in SARS-CoV-2 spike creates a variant soup from which new COVID-19 waves emerge"},{"title3":"Clinico-epidemiological profile of COVID-19 patients with Omicron variant admitted in a tertiary care center, South India"},{"title3":"Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant"},{"title3":"Where did 'weird' Omicron come from?"},{"title3":"Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa"},{"title3":"Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022"},{"title3":"Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages"},{"title3":"Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study"},{"title3":"The epidemiological characteristics of an outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020"},{"title3":"Androgens' role in severity and mortality rates of COVID-19"},{"title3":"Targeting immune dysfunction in aging"},{"title3":"Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model"},{"title3":"Incidence and predictors of breakthrough and severe breakthrough infections of SARS-CoV-2 after primary series vaccination in adults: a population-based survey of 22,575 participants"},{"title3":"Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) variant cluster - Nebraska, November-December 2021"},{"title3":"Co-infection with respiratory pathogens among COVID-2019 cases"},{"title3":"Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting"},{"title3":"Coinfection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus/enterovirus?"}]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Prognostic value of NT-proBNP in patients with severe COVID-19","References":[{"title3":"Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020:105924-4. 10.1016/j.ijantimicag.2020.105924."},{"title3":"Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Guan WJ, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. 10.1056/NEJMoa2002032."},{"title3":"Shi S, et al. Association of Cardiac Injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020. 10.1001/jamacardio.2020.0950."},{"title3":"Guo T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. 10.1001/jamacardio.2020.1017."},{"title3":"Wang D, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020. 10.1001/jama.2020.1585."},{"title3":"Prognostic value of N-terminal pro-brain natriuretic peptide in hospitalised patients with community-acquired pneumonia"},{"title3":"Is N-terminal pro-B-type natriuretic peptide ready for 'prime time' in severe pneumonia?"},{"title3":"Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia?"},{"title3":"Pneumonia as a cardiovascular disease"},{"title3":"Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence"},{"title3":"Specificity of B-type natriuretic peptide assays: cross-reactivity with different BNP, NT-proBNP, and proBNP peptides"},{"title3":"BNP in septic patients without systolic myocardial dysfunction"},{"title3":"Natriuretic peptides to predict short-term mortality in patients with sepsis: a systematic review and meta-analysis"},{"title3":"Xu Z, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020. 10.1016/S2213-2600(20)30076-X."},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Advances in the research of cytokine storm mechanism induced by Corona virus disease 2019 and the corresponding immunotherapies"},{"title3":"Management of corona virus disease-19 (COVID-19): the Zhejiang experience"},{"title3":"Is COVID-19 receiving ADE from other coronaviruses?"},{"title3":"Myocardial injury in patients with COVID-19 pneumonia"},{"title3":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020. 10.1007/s00134-020-05985-910.1007/s00134-00020-05985-00139."},{"title3":"The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)"},{"title3":"Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure"}]},{"title2":"Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: A Prospective Cohort Study","References":[]},{"title2":"A tool to early predict severe coronavirus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China","References":[]},{"title2":"Prediction models for diagnosis and prognosis of COVID-19 infection: systematic review and critical appraisal","References":[]},{"title2":"XGBoost algorithm: long may she reign! Towards Data Science","References":[]},{"title2":"XGBoost, a top machine learning method on Kaggle, explained. KD Nuggets","References":[]},{"title2":"Data integration through heterogeneous ensembles for protein function prediction","References":[]},{"title2":"Opportunities and obstacles for deep learning in biology and medicine","References":[{"title3":"Big data: astronomical or genomical?"},{"title3":"Deep learning"},{"title3":"Searching for exotic particles in high-energy physics with deep learning"},{"title3":"Deep learning for computational chemistry"},{"title3":"Dermatologist-level classification of skin cancer with deep neural networks"},{"title3":"A logical calculus of the ideas immanent in nervous activity"},{"title3":"Analysis of a four-layer series-coupled perceptron. II"},{"title3":"Deep learning for regulatory genomics"},{"title3":"Applications of deep learning in biomedicine"},{"title3":"Deep learning for computational biology"},{"title3":"Deep learning in bioinformatics ,"},{"title3":"Computer vision for high content screening"},{"title3":"Deep learning for healthcare: review, opportunities and challenges"},{"title3":"A survey on deep learning in medical image analysis"},{"title3":"Deep learning in drug discovery"},{"title3":"Virtual screening: a challenge for deep learning"},{"title3":"A renaissance of neural networks in drug discovery"},{"title3":"Supervised risk predictor of breast cancer based on intrinsic subtypes"},{"title3":"New strategies for triple-negative breast cancer:deciphering the heterogeneity"},{"title3":"Unsupervised feature construction and knowledge extraction from genome-wide assays of breast cancer with denoising autoencoders"},{"title3":"Accurate de novo prediction of protein contact map by ultra-deep learning model"},{"title3":"A deep learning network approach to ab initio protein secondary structure prediction"},{"title3":"Protein secondary structure prediction using deep convolutional neural fields"},{"title3":"Deep feature selection: theory and application to identify enhancers and promoters"},{"title3":"DEEP: a general computational framework for predicting enhancers"},{"title3":"DANN: a deep learning approach for annotating the pathogenicity of genetic variants"},{"title3":"Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data"},{"title3":"Predicting drug-target interactions using restricted Boltzmann machines"},{"title3":"Deep-learning-based drug-target interaction prediction"},{"title3":"Deep learning in medical image analysis"},{"title3":"Deep learning and structured prediction for the segmentation of mass in mammograms"},{"title3":"A deep learning approach for the analysis of masses in mammograms with minimal user intervention"},{"title3":"ImageNet large scale visual recognition challenge"},{"title3":"Convolutional neural networks for diabetic retinopathy"},{"title3":"Improved automated detection of diabetic retinopathy on a publicly available dataset through integration of deep learning"},{"title3":"Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs"},{"title3":"Automated melanoma recognition in dermoscopy images via very deep residual networks"},{"title3":"Extraction of skin lesions from non-dermoscopic images for surgical excision of melanoma"},{"title3":"Deep convolutional neural networks for computer-aided detection: CNN architectures, dataset characteristics and transfer learning"},{"title3":"High-throughput classification of radiographs using deep convolutional neural networks"},{"title3":"Deep learning at chest radiography: automated classification of pulmonary tuberculosis by using convolutional neural networks"},{"title3":"Improving computer-aided detection using convolutional neural networks and random view aggregation"},{"title3":"Large scale deep learning for computer aided detection of mammographic lesions"},{"title3":"Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis"},{"title3":"Points of significance: classification evaluation"},{"title3":"TaggerOne: joint named entity recognition and normalization with semi-Markov models"},{"title3":"tmVar: a text mining approach for extracting sequence variants in biomedical literature"},{"title3":"DNorm: disease name normalization with pairwise learning to rank"},{"title3":"Effects of semantic features on machine learning-based drug name recognition systems: word embeddings vs. manually constructed dictionaries"},{"title3":"Evaluating word representation features in biomedical named entity recognition tasks"},{"title3":"A comprehensive benchmark of kernel methods to extract protein-protein interactions from literature"},{"title3":"Improving chemical disease relation extraction with rich features and weakly labeled data"},{"title3":"Evaluation of linguistic features useful in extraction of interactions from PubMed; application to annotating known, high-throughput and predicted interactions in I2D"},{"title3":"A neural joint model for entity and relation extraction from biomedical text"},{"title3":"A shortest dependency path based convolutional neural network for protein-protein relation extraction"},{"title3":"Multichannel convolutional neural network for biological relation extraction"},{"title3":"A general protein-protein interaction extraction architecture based on word representation and feature selection"},{"title3":"Chemical-induced disease relation extraction via convolutional neural network"},{"title3":"Drug drug interaction extraction from biomedical literature using syntax convolutional neural network"},{"title3":"Embedding assisted prediction architecture for event trigger identification"},{"title3":"Realizing the full potential of electronic health records: the role of natural language processing"},{"title3":"Machine-learned solutions for three stages of clinical information extraction: the state of the art at i2b2 2010"},{"title3":"Exploring the application of deep learning techniques on medical text corpora"},{"title3":"Large-scale discovery of disease-disease and disease-gene associations"},{"title3":"Computational phenotype discovery using unsupervised feature learning over noisy, sparse, and irregular clinical data"},{"title3":"Semi-supervised learning of the electronic health record for phenotype stratification"},{"title3":"Deep patient: an unsupervised representation to predict the future of patients from the electronic health records"},{"title3":"Deepr: a convolutional net for medical records"},{"title3":"Comparison of the performance of neural network methods and Cox regression for censored survival data"},{"title3":"A machine learning-based framework to identify type 2 diabetes through electronic health records"},{"title3":"Electronic medical record phenotyping using the anchor and learn framework"},{"title3":"Mining electronic health records: towards better research applications and clinical care"},{"title3":"Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research"},{"title3":"Impact of electronic health record systems on information integrity: quality and safety implications"},{"title3":"Secondary use of EHR: data quality issues and informatics opportunities"},{"title3":"Have DRG-based prospective payment systems influenced the number of secondary diagnoses in health care administrative data?"},{"title3":"Why patient matching is a challenge: research on master patient index (MPI) data discrepancies in key identifying fields"},{"title3":"Identifying and mitigating biases in EHR laboratory tests"},{"title3":"Using electronic health records for clinical research: the case of the EHR4CR project"},{"title3":"How sample size influences research outcomes"},{"title3":"A review of approaches to identifying patient phenotype cohorts using electronic health records"},{"title3":"Strategies for equitable pharmacogenomic-guided warfarin dosing among European and African American individuals in a clinical population"},{"title3":"Epidemiological research labelled as a violation of privacy: the case of Estonia"},{"title3":"Harnessing next-generation informatics for personalizing medicine: a report from AMIA's 2014 Health Policy invitational meeting"},{"title3":"DataSHIELD: taking the analysis to the data, not the data to the analysis"},{"title3":"ViPAR: a software platform for the virtual pooling and analysis of research data"},{"title3":"Reproducibility of computational workflows is automated using continuous analysis"},{"title3":"The algorithmic foundations of differential privacy"},{"title3":"Enabling privacy-preserving GWASs in heterogeneous human populations"},{"title3":"Overcoming the winner's curse: estimating penetrance parameters from case-control data"},{"title3":"Sex bias in neuroscience and biomedical research"},{"title3":"Generalization and dilution of association results from European GWAS in populations of non-European ancestry: the PAGE study"},{"title3":"New approaches to population stratification in genome-wide association studies"},{"title3":"Retraction"},{"title3":"Leakage in data mining"},{"title3":"To predict and serve?"},{"title3":"The Framingham heart study and the epidemiology of cardiovascular disease: a historical perspective"},{"title3":"Children of the 90s: coming of age"},{"title3":"Nonparametric estimation from incomplete observations"},{"title3":"Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients"},{"title3":"Multi-omics integration accurately predicts cellular state in unexplored conditions for Escherichia coli"},{"title3":"Trans-species learning of cellular signaling systems with bimodal deep belief networks"},{"title3":"Learning a hierarchical representation of the yeast transcriptomic machinery using an autoencoder model"},{"title3":"ADAGE-based integration of publicly available Pseudomonas aeruginosa gene expression data with denoising autoencoders illuminates microbe-host interactions"},{"title3":"Gene expression inference with deep learning"},{"title3":"Integrative data analysis of multi-platform cancer data with a multimodal deep learning approach"},{"title3":"RNA mis-splicing in disease"},{"title3":"RNA splicing is a primary link between genetic variation and disease"},{"title3":"Deciphering the splicing code"},{"title3":"Bayesian prediction of tissue-regulated splicing using RNA sequence and cellular context"},{"title3":"The human splicing code reveals new insights into the genetic determinants of disease"},{"title3":"Imputation for transcription factor binding predictions based on deep learning"},{"title3":"Learning the sequence determinants of alternative splicing from millions of random sequences"},{"title3":"Mechanisms in endocrinology: alternative splicing: the new frontier in diabetes research"},{"title3":"Absence of a simple code: how transcription factors read the genome"},{"title3":"An integrated encyclopedia of DNA elements in the human genome"},{"title3":"DNA binding sites: representation and discovery"},{"title3":"MEME SUITE: tools for motif discovery and searching"},{"title3":"Evaluation of methods for modeling transcription factor sequence specificity"},{"title3":"High resolution models of transcription factor-DNA affinities improve in vitro and in vivo binding predictions"},{"title3":"Enhanced regulatory sequence prediction using gapped k-mer features"},{"title3":"Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning"},{"title3":"RNA-protein binding motifs mining with a new hybrid deep learning based cross-domain knowledge integration approach"},{"title3":"Convolutional neural network architectures for predicting DNA-protein binding"},{"title3":"Predicting effects of noncoding variants with deep learning-based sequence model"},{"title3":"DanQ: a hybrid convolutional and recurrent deep neural network for quantifying the function of DNA sequences"},{"title3":"Sequence and chromatin determinants of cell-type-specific transcription factor binding"},{"title3":"Analysis of computational footprinting methods for DNase sequencing experiments"},{"title3":"Transfer string kernel for cross-context DNA-protein binding prediction"},{"title3":"The state of the art of mammalian promoter recognition"},{"title3":"Detection of RNA polymerase II promoters and polyadenylation sites in human DNA sequence"},{"title3":"Recognition of prokaryotic and eukaryotic promoters using convolutional deep learning neural networks"},{"title3":"Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage"},{"title3":"Genome-wide characterization of transcriptional start sites in humans by integrative transcriptome analysis"},{"title3":"Enhancers: five essential questions"},{"title3":"A unified architecture of transcriptional regulatory elements"},{"title3":"Basset: learning the regulatory code of the accessible genome with deep convolutional neural networks"},{"title3":"A network-biology perspective of microRNA function and dysfunction in cancer"},{"title3":"Evolution of microRNA diversity and regulation in animals"},{"title3":"Predicting effective microRNA target sites in mammalian mRNAs"},{"title3":"MetaPSICOV: combining coevolution methods for accurate prediction of contacts and long range hydrogen bonding in proteins"},{"title3":"Identification of direct residue contacts in protein-protein interaction by message passing"},{"title3":"Protein 3D structure computed from evolutionary sequence variation"},{"title3":"A unified multitask architecture for predicting local protein properties"},{"title3":"Improving prediction of secondary structure, local backbone angles and solvent accessible surface area of proteins by iterative deep learning"},{"title3":"Protein secondary structure prediction based on position-specific scoring matrices"},{"title3":"Protein contact prediction by integrating joint evolutionary coupling analysis and supervised learning"},{"title3":"Deep architectures for protein contact map prediction"},{"title3":"Predicting protein residue-residue contacts using deep networks and boosting"},{"title3":"Improved contact predictions using the recognition of protein like contact patterns"},{"title3":"Single-particle Cryo-EM at crystallographic resolution"},{"title3":"A primer to single-particle cryo-electron microscopy"},{"title3":"SwarmPS: rapid, semi-automated single particle selection software"},{"title3":"Semi-automated selection of cryo-EM particles in RELION-1.3"},{"title3":"DeepPicker: a deep learning approach for fully automated particle picking in cryo-EM"},{"title3":"A deep convolutional neural network approach to single-particle recognition in cryo-electron microscopy"},{"title3":"Massively parallel unsupervised single-particle cryo-EM data clustering via statistical manifold learning"},{"title3":"Protein-protein interactions essentials: key concepts to building and analyzing interactome networks"},{"title3":"Extracting interactions between proteins from the literature"},{"title3":"DeepPPI: boosting prediction of protein-protein interactions with deep neural networks"},{"title3":"Sequence-based prediction of protein-protein interaction using a deep-learning algorithm"},{"title3":"Predicting protein-protein interactions from protein sequences by a stacked sparse autoencoder deep neural network"},{"title3":"Prediction of residue-residue contact matrix for protein-protein interaction with Fisher score features and deep learning"},{"title3":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations"},{"title3":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system"},{"title3":"NetMHCpan, a method for MHC class I binding prediction beyond humans"},{"title3":"NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets"},{"title3":"High-order neural networks and kernel methods for peptide-MHC binding prediction"},{"title3":"HLA class I binding prediction via convolutional neural networks"},{"title3":"Network-based prediction of protein function"},{"title3":"Learning the structural vocabulary of a network"},{"title3":"Deep learning automates the quantitative analysis of individual cells in live-cell imaging experiments"},{"title3":"U-net: convolutional networks for biomedical image segmentation"},{"title3":"Prospective identification of hematopoietic lineage choice by deep learning"},{"title3":"Applications in image-based profiling of perturbations"},{"title3":"Large-scale image-based screening and profiling of cellular phenotypes"},{"title3":"Machine learning and computer vision approaches for phenotypic profiling"},{"title3":"Single-cell genome sequencing: current state of the science"},{"title3":"Somatic mutation in single human neurons tracks developmental and transcriptional history"},{"title3":"Single-cell transcriptome sequencing: recent advances and remaining challenges"},{"title3":"Single-cell and single-molecule analysis of gene expression regulation"},{"title3":"DeepCpG: accurate prediction of single-cell DNA methylation states using deep learning"},{"title3":"Removal of batch effects using distribution-matching residual networks"},{"title3":"Single-cell genomics unveils critical regulators of Th17 cell pathogenicity"},{"title3":"Visualizing data using t-SNE"},{"title3":"Using neural networks for reducing the dimensions of single-cell RNA-Seq data"},{"title3":"Science forum: the human cell atlas"},{"title3":"Mastering the game of Go with deep neural networks and tree search"},{"title3":"Compositional biases of bacterial genomes and evolutionary implications"},{"title3":"Accurate phylogenetic classification of variable-length DNA fragments"},{"title3":"NBC: the Naive Bayes Classification tool webserver for taxonomic classification of metagenomic reads"},{"title3":"Informatics for unveiling hidden genome signatures"},{"title3":"Metagenomic microbial community profiling using unique clade-specific marker genes"},{"title3":"WGSQuikr: fast whole-genome shotgun metagenomic classification"},{"title3":"Scalable metagenomic taxonomy classification using a reference genome database"},{"title3":"Large-scale machine learning for metagenomics sequence classification"},{"title3":"Combining gene prediction methods to improve metagenomic gene annotation"},{"title3":"Machine learning for metagenomics: methods and tools"},{"title3":"Utilizing machine learning approaches to understand the interrelationship of diet, the human gastrointestinal microbiome, and health"},{"title3":"Supervised classification of human microbiota"},{"title3":"A comprehensive evaluation of multicategory classification methods for microbiomic data"},{"title3":"Machine learning meta-analysis of large metagenomic datasets: tools and biological insights"},{"title3":"DectICO: an alignment-free supervised metagenomic classification method based on feature extraction and dynamic selection"},{"title3":"Correction: class prediction and feature selection with linear optimization for metagenomic count data"},{"title3":"Fizzy: feature subset selection for metagenomics"},{"title3":"A bootstrap based Neyman-Pearson test for identifying variable importance"},{"title3":"Orphelia: predicting genes in metagenomic sequencing reads"},{"title3":"FragGeneScan: predicting genes in short and error-prone reads"},{"title3":"Continuous distributed representation of biological sequences for deep proteomics and genomics"},{"title3":"Fast model-based protein homology detection without alignment"},{"title3":"Clustering metagenomic sequences with interpolated Markov models"},{"title3":"Metagenomic taxonomic classification using extreme learning machines"},{"title3":"Influence of microbiome species in hard-to-heal wounds on disease severity and treatment duration"},{"title3":"Multi-layer and recursive neural networks for metagenomic classification"},{"title3":"DeepNano: deep recurrent neural networks for base calling in MinION nanopore reads"},{"title3":"A framework for variation discovery and genotyping using next-generation DNA sequencing data"},{"title3":"Toward an integration of deep learning and neuroscience"},{"title3":"Neuroscience-Inspired artificial intelligence"},{"title3":"Using goal-driven deep learning models to understand sensory cortex"},{"title3":"Machines that learn to segment images: a crucial technology for connectomics"},{"title3":"The path to personalized medicine"},{"title3":"Biomedical informatics for computer-aided decision support systems: a survey"},{"title3":"Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes"},{"title3":"Use of an artificial neural network for the diagnosis of myocardial infarction"},{"title3":"Clinical prediction rules"},{"title3":"The use of artificial neural networks in decision support in cancer: a systematic review"},{"title3":"Estimating causal effects of treatments in randomized and nonrandomized studies"},{"title3":"Predicting complications in critical care using heterogeneous clinical data"},{"title3":"From vital signs to clinical outcomes for patients with sepsis: a machine learning basis for a clinical decision support system"},{"title3":"Imaging-based enrichment criteria using deep learning algorithms for efficient clinical trials in mild cognitive impairment"},{"title3":"Innovation in the pharmaceutical industry: new estimates of R&amp;D costs"},{"title3":"An analysis of the attrition of drug candidates from four major pharmaceutical companies"},{"title3":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease"},{"title3":"A survey of current trends in computational drug repositioning"},{"title3":"A review of connectivity map and computational approaches in pharmacogenomics"},{"title3":"A review of validation strategies for computational drug repositioning"},{"title3":"Drug repositioning: a machine-learning approach through data integration"},{"title3":"Drug-disease association and drug-repositioning predictions in complex diseases using causal inference-probabilistic matrix factorization"},{"title3":"Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory"},{"title3":"Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties"},{"title3":"Large-scale integration of small-molecule induced genome-wide transcriptional responses, Kinome-wide binding affinities and cell-growth inhibition profiles reveal global trends characterizing systems-level drug action"},{"title3":"Computational discovery of putative leads for drug repositioning through drug-target interaction prediction"},{"title3":"Large-scale off-target identification using fast and accurate dual regularized one-class collaborative filtering and its application to drug repurposing"},{"title3":"L1000CDS2: LINCS L1000 characteristic direction signatures search engine"},{"title3":"A guide to drug discovery: hit and lead generation: beyond high-throughput screening"},{"title3":"Hit discovery and hit-to-lead approaches"},{"title3":"Influence relevance voting: an accurate and interpretable virtual high throughput screening method"},{"title3":"XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks"},{"title3":"Deep neural nets as a method for quantitative structure-activity relationships"},{"title3":"DeepTox: toxicity prediction using deep learning"},{"title3":"Computational modeling of beta-secretase 1 (BACE-1) inhibitors using ligand based approaches"},{"title3":"The enumeration of chemical space"},{"title3":"Accurate and efficient target prediction using a potency-sensitive influence-relevance voter"},{"title3":"Extended-connectivity fingerprints"},{"title3":"Deep architectures and deep learning in chemoinformatics: the prediction of aqueous solubility for drug-like molecules"},{"title3":"Molecular graph convolutions: moving beyond fingerprints"},{"title3":"Low data drug discovery with one-shot learning"},{"title3":"Convolutional embedding of attributed molecular graphs for physical property prediction"},{"title3":"Learning a local-variable model of aromatic and conjugated systems"},{"title3":"MoleculeNet: a benchmark for molecular machine learning"},{"title3":"What do we know and when do we know it?"},{"title3":"Mol2vec: unsupervised machine learning approach with chemical intuition"},{"title3":"Structure-based virtual screening for drug discovery: a problem-centric review"},{"title3":"TopologyNet: topology based deep convolutional and multi-task neural networks for biomolecular property predictions"},{"title3":"The PDBbind database: methodologies and updates"},{"title3":"Boosting docking-based virtual screening with deep learning"},{"title3":"Enabling future drug discovery by denovo design"},{"title3":"De novo design at the edge of chaos"},{"title3":"ChEMBL: a large-scale bioactivity database for drug discovery"},{"title3":"An open investigation of the reproducibility of cancer biology research"},{"title3":"Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods"},{"title3":"Confidence interval prediction for neural network models"},{"title3":"Leveraging uncertainty information from deep neural networks for disease detection"},{"title3":"Uncertainty in deep learning"},{"title3":"'"},{"title3":"On pixel-wise explanations for non-linear classifier decisions by layer-wise relevance propagation"},{"title3":"Visualizing deep convolutional neural networks using natural pre-images"},{"title3":"The cancer genome atlas pan-cancer analysis project"},{"title3":"Functional knowledge transfer for high-accuracy prediction of under-studied biological processes"},{"title3":"A general framework for estimating the relative pathogenicity of human genetic variants"},{"title3":"Deep learning in neural networks: an overview"},{"title3":"Growing pains for deep learning"},{"title3":"CGBVS-DNN: prediction of compound-protein interactions based on deep learning"},{"title3":"MapReduce"},{"title3":"Distributed GraphLab: a framework for machine learning and data mining in the cloud"},{"title3":"Random search for hyper-parameter optimization"},{"title3":"Cloud computing and the DNA data race"},{"title3":"The real cost of sequencing: scaling computation to keep pace with data generation"},{"title3":"The case for cloud computing in genome informatics"},{"title3":"A view of cloud computing"},{"title3":"Data sharing"},{"title3":"Celebrating parasites"},{"title3":"Is multitask deep learning practical for pharma?"},{"title3":"Enhancing reproducibility for computational methods"},{"title3":"Deep convolutional neural networks for annotating gene expression patterns in the mouse brain"},{"title3":"Accurate classification of protein subcellular localization from high-throughput microscopy images using deep learning"},{"title3":"Automated analysis of high-content microscopy data with deep learning"},{"title3":"Modeling reactivity to biological macromolecules with a deep multitask network"}]}]},{"title1":"Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study","References":[{"title2":"A new coronavirus associated with human respiratory disease in China","References":[]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Nanshan Chen MZ, Xuan Dong, Jieming Qu, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223):507-513.","References":[]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"World Health Organization. Novel coronavirus (COVID-19): situation report-141. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200609-covid-19-sitrep-141.pdf?sfvrsn=72fa1b16_2 (Accessed 9 June 2020).","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020. 10.1183/13993003.00524-2020.","References":[]},{"title2":"Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020. 10.1001/jamainternmed.2020.0994.","References":[]},{"title2":"Xie J, Hungerford D, Chen H, et al. Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19. medRxiv [Preprint] 2020; doi:10.1101/2020.03.28.20045997.","References":[]},{"title2":"Lu J, Hu S, Fan R, et al. ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China. medRxiv [Preprint] 2020; doi:10.1101/2020.02.20.20025510.","References":[]},{"title2":"Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation"},{"title3":"Mechanisms of eosinophil-associated inflammation"},{"title3":"30 day mortality and eosinopenia in patients with pneumonia"},{"title3":"Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen"},{"title3":"IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection"},{"title3":"CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily"}]},{"title2":"Yeming W, Dingyu Z, Guanhua D, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. 2020; DOI: 10.1016/S0140-6736(20)31022-9.","References":[]},{"title2":"National Health Commission of China. The guidelines of the diagnosis and treatment of new coronavirus pneumonia (version7). http://www.gov.cn/zhengce/zhengceku/2020-03/04/content_5486705.htm (Accessed 6 Mar 2020).","References":[]},{"title2":"Calculating the sample size required for developing a clinical prediction model","References":[]},{"title2":"Development and reporting of prediction models: guidance for authors from editors of respiratory, sleep, and critical care journals","References":[{"title3":"Prognosis and prognostic research: Validating a prognostic model."},{"title3":"Prognosis and prognostic research: Application and impact of prognostic models in clinical practice."},{"title3":"Prognosis and prognostic research: What, why, and how?"},{"title3":"Prognosis and prognostic research: Developing a prognostic model."},{"title3":"Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)."},{"title3":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration."},{"title3":"Control of confounding and reporting of results in causal inference studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals."},{"title3":"To explain or to predict?"},{"title3":"Acute Physiology and Chronic Health Evaluation (APACHE) IV: Hospital mortality assessment for today's critically ill patients."},{"title3":"Machine learning, health disparities, and causal reasoning."},{"title3":"Race, ethnicity and lung function: A brief history."},{"title3":"Reconsidering the consequences of using race to estimate kidney function."},{"title3":"Potential biases in machine learning algorithms using electronic health record data."},{"title3":"Ensuring fairness in machine learning to advance health equity."},{"title3":"Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis."},{"title3":"Step away from stepwise."},{"title3":"The problem of overfitting."},{"title3":"Stepwise model fitting and statistical inference: Turning noise into signal pollution."},{"title3":"Variable selection: current practice in epidemiological studies."},{"title3":"The ASA's statement on p-Values: Context, process, and purpose."},{"title3":"Application of shrinkage techniques in logistic regression analysis: A case study."},{"title3":"Minimum sample size for developing a multivariable prediction model: Part I - Continuous outcomes."},{"title3":"PROBAST: A tool to assess risk of bias and applicability of prediction model studies: Explanation and elaboration."},{"title3":"Minimum sample size for developing a multivariable prediction model: PART II - Binary and time-to-event outcomes."},{"title3":"Sample size for binary logistic prediction models: Beyond events per variable criteria."},{"title3":"Dichotomania: An obsessive compulsive disorder that is badly affecting the quality of analysis of pharmaceutical trials."},{"title3":"Dichotomizing continuous predictors in multiple regression: A bad idea."},{"title3":"A new insight into missing data in intensive care unit patient profiles: Observational study."},{"title3":"Missing data."},{"title3":"Advanced statistics: Missing data in clinical research-Part 2: Multiple imputation."},{"title3":"What do we mean by validating a prognostic model?"},{"title3":"Towards better clinical prediction models: Seven steps for development and an ABCD for validation."},{"title3":"A new concordance measure for risk prediction models in external validation settings."},{"title3":"A new framework to enhance the interpretation of external validation studies of clinical prediction models."},{"title3":"External validity of risk models: Use of benchmark values to disentangle a case-mix effect from incorrect coefficients."},{"title3":"Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis."},{"title3":"Customization of a severity of illness score using local electronic medical record data."},{"title3":"Assessing the performance of prediction models: A framework for traditional and novel measures."},{"title3":"Discrimination and calibration of clinical prediction models: Users' guides to the medical literature."},{"title3":"Rare events in the ICU: An emerging challenge in classification and prediction."}]},{"title2":"Gong J, Ou J, Qiu X, et al. A tool to early predict severe 2019-novel coronavirus pneumonia (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa443.","References":[]},{"title2":"Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020; e202033. doi: 10.1001/jamainternmed.2020.2033.","References":[]},{"title2":"Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage","References":[]},{"title2":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)","References":[]},{"title2":"Hematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis","References":[]},{"title2":"Advanced statistics: missing data in clinical research--part 2: multiple imputation","References":[]},{"title2":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","References":[]},{"title2":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Novel coronavirus:China"},{"title3":"Coronavirus disease (COVID-19) outbreak"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Notes from the field: a novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Novel coronavirus:Thailand (ex-China)"},{"title3":"Novel coronavirus:Japan (ex-China)"},{"title3":"Novel coronavirus:Republic of Korea (ex-China)"},{"title3":"First travel-related case of 2019 novel coronavirus detected in United States"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China"},{"title3":"Clinical features and factors associated with outcomes of patients infected with a novel influenza A (H7N9) virus: a preliminary study"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: radiologic findings"},{"title3":"Severe acute respiratory syndrome: radiographic and CT findings"},{"title3":"Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Clinical and imaging findings in patients with severe acute respiratory syndrome"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"The radiologic manifestations of H5N1 avian influenza"},{"title3":"Organizing pneumonia: perilobular pattern at thin-section CT"},{"title3":"An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias"}]},{"title2":"Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"An interpretable mortality prediction model for COVID-19 patients","References":[]}]},{"title1":"The De Ritis ratio as prognostic biomarker of in?hospital mortality in COVID?19 patients","References":[{"title2":"Possible bat origin of severe acute respiratory syndrome coronavirus 2","References":[{"title3":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2."},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats."},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor."},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus."},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"Viral metagenomics revealed sendai virus and coronavirus infection of Malayan pangolins (Manis javanica)."},{"title3":"Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins."},{"title3":"Molecular epidemiology, evolution and phylogeny of SARS coronavirus."},{"title3":"Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events."},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2."},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2."},{"title3":"Polyphyletic origin of MERS coronaviruses and isolation of a novel clade A strain from dromedary camels in the United Arab Emirates."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."}]},{"title2":"Xx","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Risk factors associated with disease severity and length of hospital stay in COVID-19 patients","References":[{"title3":"Wuhan and hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by Olmesartan, an angiotensin ii receptor blocker"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin ii receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia"},{"title3":"[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]"}]},{"title2":"Objective evaluation of anosmia and ageusia in COVID-19 patients: single-center experience on 72 cases","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study"},{"title3":"Anosmia and ageusia: common findings in COVID-19 patients"},{"title3":"Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?"},{"title3":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study"},{"title3":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study"},{"title3":"Clinical evaluation of olfaction"},{"title3":"Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center"},{"title3":"Retronasal and orthonasal olfactory ability after laryngectomy"},{"title3":"Evaluation of olfactory function in children with seasonal allergic rhinitis and its correlation with acoustic rhinometry"},{"title3":"Connecticut (CCCRC) olfactory test: normative values in 426 healthy volunteers"},{"title3":"Sensory recovery of myomucosal flap oral cavity reconstructions"},{"title3":"Oral sensation and function: a comparison of patients with innervated radial forearm free flap reconstruction to healthy matched controls"},{"title3":"Age-related deficits in taste and smell"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"}]},{"title2":"Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy","References":[]},{"title2":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","References":[{"title3":"Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Tuberculosis and diabetes mellitus: convergence of two epidemics"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score"},{"title3":"Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity &amp; Mortality (HIMM) surveillance"},{"title3":"Summary of the 2018 report on cardiovascular diseases in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Burden of diabetes, hyperglycaemia in China from to 2016: findings from the 1990 to 2016, global burden of disease study"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis"},{"title3":"Connecting type 1 and type 2 diabetes through innate immunity"},{"title3":"Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Evolving reporting criteria of COVID-19 in Taiwan during the epidemic","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"WHO. Coronavirus disease 2019 (COVID-19). Situation Report-55. (https://www.who.int/docs/default-source/coronaviruse/20200312-sitrep-52-covid-19.pdf?sfvrsn=e2bfc9c0_2)."},{"title3":"Global surveillance for COVID-19 disease caused by human infection with the 2019 novel coronavirus"},{"title3":"Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing"},{"title3":"COVID-19. Taiwan Centers for Disease Control. https://www.cdc.gov.tw/Category/MPage/V6Xe4EItDW3NdGTgC5PtKA."},{"title3":"COVID-19. Taiwan Centers for Disease Control. Accessed March 16, 2020. https://www.cdc.gov.tw/Disease/SubIndex/N6XvFa1YP9CXYdB0kNSA9A."},{"title3":"2019 novel coronavirus disease (COVID-19) in Taiwan: reports of two cases from Wuhan, China"},{"title3":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): facts and myths"}]},{"title2":"Coronavirus pathogenesis","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"The coronavirus disease 2019 (COVID-19) pandemic"},{"title3":"Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?"},{"title3":"COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS"},{"title3":"Covid19, beyond just the lungs: a review of multisystemic involvement by Covid19"},{"title3":"In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19"},{"title3":"Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease"},{"title3":"Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"Pathophysiological association of endothelial dysfunction with fatal outcome in COVID-19"},{"title3":"Pulmonary endothelial dysfunction and thrombotic complications in patients with COVID-19"},{"title3":"COVID-19: the vasculature unleashed"},{"title3":"Patterns of inflammatory cell infiltration and expression of STAT6 in the lungs of patients with COVID-19: an autopsy study"},{"title3":"Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation"},{"title3":"The spatial landscape of lung pathology during COVID-19 progression"},{"title3":"A molecular single-cell lung atlas of lethal COVID-19"},{"title3":"Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis"},{"title3":"The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single cell resolution"},{"title3":"Endothelial deficiency of insulin-like growth factor-1 receptor reduces endothelial barrier function and promotes atherosclerosis in Apoe-deficient mice"},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19"},{"title3":"Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures"},{"title3":"Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures"},{"title3":"Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection"},{"title3":"Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Physiology of cardiomyocyte injury in COVID-19"},{"title3":"SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes"},{"title3":"The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells"},{"title3":"The cross-talk of lung and heart complications in COVID-19: endothelial cells dysfunction, thrombosis, and treatment"},{"title3":"COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets"},{"title3":"Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry"},{"title3":"SARS-CoV-2 productively infects human brain microvascular endothelial cells"},{"title3":"The good treatment, the bad virus, and the ugly inflammation: pathophysiology of kidney involvement during COVID-19"},{"title3":"Pathophysiology of COVID-19-associated acute kidney injury"},{"title3":"Endothelial dysfunction for acute kidney injury in coronavirus disease 2019: how concerned should we be?"},{"title3":"Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches"},{"title3":"Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19"},{"title3":"Circulating endothelial cells as a marker of endothelial injury in severe COVID -19"},{"title3":"COVID-19 and the endothelium"},{"title3":"Emerging role of neuropilin-1 and angiotensin-converting enzyme-2 in renal carcinoma-associated COVID-19 pathogenesis"},{"title3":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19"},{"title3":"COVID-19 vasculopathy: mounting evidence for an indirect mechanism of endothelial injury"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes"},{"title3":"Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients"},{"title3":"Heart-lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement"},{"title3":"Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)"},{"title3":"Compassionate use of remdesivir for patients with severe Covid-19"},{"title3":"Potential specific therapies in COVID-19"},{"title3":"Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets"},{"title3":"A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4"},{"title3":"Dexamethasone in hospitalized patients with Covid-19"},{"title3":"Resistance of endothelial cells to SARS-CoV-2 infection in vitro Blerina Ahmetaj-Shala"},{"title3":"The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo"},{"title3":"Evolving functions of endothelial cells in inflammation"},{"title3":"Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"COVID-19, MERS and SARS with concomitant liver injury-systematic review of the existing literature","References":[{"title3":"The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical Management of Severe Acute Respiratory Infection (SARI) when COVID-19 Disease is Suspected: Interim Guidance"},{"title3":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms"},{"title3":"Clinical Characteristics of COVID-19 Patients with Digestive Symptoms in Hubei, China"},{"title3":"COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission"},{"title3":"COVID-19: Gastrointestinal symptoms and potential sources of 2019-nCoV transmission"},{"title3":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection:clinicopathological and ultrastructural study"},{"title3":"Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single center in Wuhan city, China"},{"title3":"COVID-19 and the liver: Little cause for concern"},{"title3":"Liver injury during highly pathogenic human coronavirus infections"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: Report of three cases"},{"title3":"PRISMA-P Group Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation"},{"title3":"STROBE Initiative Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: A multicenter study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study"},{"title3":"Liver injury in COVID-19: Management and challenges"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series"},{"title3":"Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study"},{"title3":"Retrospective analysis of liver function derangement in severe acute respiratory syndrome"},{"title3":"Clinical significance of hepatic derangement in severe acute respiratory syndrome"},{"title3":"[Morphological study of severe acute respiratory syndrome (SARS)]"},{"title3":"Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: Retrospective analysis"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): A report from China"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"[Study on the damage of liver in patients with SARS]"},{"title3":"A follow-up study of 69 discharged SARS patients"},{"title3":"Clinicopathology of severe acute respiratory syndrome: An autopsy case report"},{"title3":"Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening"},{"title3":"A clinicopathological study on 3 cases of severe acute respiratory syndrome"},{"title3":"Clinical features and therapy of 106 cases of severe acute respiratory syndrome"},{"title3":"Case report of the first Severe Acute Respiratory Syndrome patient in China: Successful application of extracorporeal liver support MARS therapy in multiorgan failure possibly induced by Severe Acute Respiratory Syndrome"},{"title3":"Effect of SARS-associated coronavirus on peripheral blood picture and liver function"},{"title3":"Clinical analysis of multiple organ dysfunction syndrome in patients suffering from SARS"},{"title3":"Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome"},{"title3":"Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome"},{"title3":"Temporal patterns of hepatic dysfunction and disease severity in patients with SARS"},{"title3":"[Changes of liver function in patients with serious acute respiratory syndrome]"},{"title3":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases"},{"title3":"Clinical features of severe acute respiratory syndrome in forty-one confirmed health care workers"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus"},{"title3":"Clinical characteristics and outcome of ICU admitted MERS corona virus infected patients"},{"title3":"[Clinical analysis of the first patient with imported Middle East respiratory syndrome in China]"},{"title3":"Clinical and Laboratory Findings of the First Imported Case of Middle East Respiratory Syndrome Coronavirus to the United States"},{"title3":"Epidemiological and Clinical Characteristics of Patients with Middle East Respiratory Syndrome Coronavirus in Iran in 2014"},{"title3":"Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: Demographic, clinical and survival data"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia"},{"title3":"Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014"},{"title3":"Clinical characteristics of Non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A Retrospective study"},{"title3":"ACE2 Is the SARS-CoV-2 Receptor Required for Cell Entry"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues"},{"title3":"Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2"},{"title3":"A gut-vascular barrier controls the systemic dissemination of bacteria"},{"title3":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)"},{"title3":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development"},{"title3":"FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis"},{"title3":"Mechanisms and consequences of gut commensal translocation in chronic diseases"},{"title3":"Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies"},{"title3":"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy"},{"title3":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016"},{"title3":"Acute respiratory distress syndrome: The Berlin Definition"},{"title3":"Acute Kidney Injury (AKI):KDIGO"},{"title3":"SCCM | COVID-19 Guidelines"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State"},{"title3":"Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses"},{"title3":"Cholangiocyte pathobiology"},{"title3":"Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: A TNF-alpha/IL-6-dependent mechanism"},{"title3":"Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis"},{"title3":"Obesity and its Implications for COVID-19 Mortality"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway"},{"title3":"Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome"},{"title3":"Clinical and Laboratory Findings of Middle East Respiratory Syndrome Coronavirus Infection"},{"title3":"Critically Ill Patients with the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"The multifunctional or moonlighting protein CD26/DPPIV"},{"title3":"Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus"},{"title3":"Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis"}]},{"title2":"Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis","References":[]},{"title2":"novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","References":[]},{"title2":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019 [published online ahead of print, 2020 Jan 24]"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published online ahead of print, 2020 Jan 24]"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia [published online ahead of print, 2020 Jan 29]"},{"title3":"N. Chen, M. Zhou, X. Dong et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. [published online ahead of print, 2020 Jan 29]. Lancet."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [published online ahead of print, 2020 Jan 24]"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [published online ahead of print, 2020 Feb 7]"},{"title3":"National health commission of the People's Republic of China. http://www.nhc.gov.cn/xcs/yqtb/202002/4a611bc7fa20411f8ba1c8084426c0d4.shtml"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China [published online ahead of print, 2020 Feb 7]"},{"title3":"Wei-jie Guan, Zheng-yi Ni, Yu Hu, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv2020.02.06.20020974."},{"title3":"Global trends in emerging infectiousdiseases"},{"title3":"Emerging pathogens: the epidemiology and evolution of species jumps"},{"title3":"Virulence evolution and the trade-off hypothesis:history, current state of affairs and the future"},{"title3":"Infectious diseases society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults"},{"title3":"A prediction rule to identify low-risk patients with community-acquired pneumonia"},{"title3":"Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study"},{"title3":"Thin-section ct of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Yongdao Zhou, Jianghu Dong. Statistical inference for coronavirus infected patients in Wuhan. medRxiv2020.02.10.20021774;"},{"title3":"Inference of R(0) and transmission heterogeneity from the size distribution of stuttering chains"},{"title3":"Emerging Coronavirus 2019-nCoV Pneumonia [published online ahead of print, 2020 Feb 6]"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Severe acute respiratory syndrome: radiographic and CT findings"},{"title3":"High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission"},{"title3":"High-resolution CT findings in patients with severe acute respiratory syndrome: a pattern-based approach"},{"title3":"Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Middle east respiratory syndrome coronavirus: what does a radiologist need to know?"},{"title3":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing"}]},{"title2":"Characteristics of COVID-19 infection in Beijing","References":[]},{"title2":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases","References":[{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Hepatic regeneration in humans with various liver disease as assessed by Ki-67 staining of formalin-fixed paraffin-embedded liver tissue"},{"title3":"Enhanced detection of the coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"The genome seqence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene"},{"title3":"Comparison of mouse hepatitis virus strains for pathogenicity in weanling mice infected by various routes"},{"title3":"Mouse hepatitis virus type 4 (JHM strains) induced fatal central nervous system disease: genetic control and murine neuron as the susceptable site of disease"},{"title3":"Experimental demyelination produced by the A59 strain of mouse hepatitis virus"},{"title3":"Murine coronavirus spike glycoprotein: receptor binding and membrane fusion activities"},{"title3":"Coronavirus spike proteins in viral entry and pathogenesis"},{"title3":"Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis"},{"title3":"Quantitative analysis and prognostic implication of SARS-coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Hepatocellular proliferation in patients with chronic hepatitis C and persistenly normal or abnormal aminotransferase level"},{"title3":"Liver regeneration is not altered in patients with nonalcoholic steatohepatitis (NASH) when compared to chronic hepatitis C infection with similar grade of inflammation"},{"title3":"Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division"},{"title3":"The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus"},{"title3":"Hepatic pathology resulting from mouse hepatitis virus S infection in severe combined immunodeficiency mice"},{"title3":"Induction of caspase-dependent apoptosis in cultured cells by the avian coronavirus infectious bronchitis virus"},{"title3":"The viral nucleocapsid protein of transmissible gastroenteritis coronavirus (TGEV) is cleaved by caspase-6 and -7 during TGEV-induced apoptosis"},{"title3":"Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Treatment-Kaletra"},{"title3":"Kaletra (lopinavir/ritonavir)"},{"title3":"Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection"},{"title3":"Mitochondrial toxic effects and ribavirin"},{"title3":"Liver disease in HIV: an update"},{"title3":"Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir"},{"title3":"Hepatotoxicity associated with ritonavir"},{"title3":"Budesonide-induced acute hepatitis in an HIV-positive patient with ritonavir as a co-medication"},{"title3":"Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir"},{"title3":"Ribavirin inhibits protein synthesis and cell proliferation induced by mitogenic factors in primary human and rat hepatocytes"},{"title3":"Prolonged therapy of chronic hepatitis C with ribavirin"},{"title3":"Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study"},{"title3":"Incidence of and risk factors for severe hepatotoxicity associated with antiretorviral combination therapy"},{"title3":"Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine"},{"title3":"Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine cohort, France, 1996-1998"}]},{"title2":"Liver injury in COVID-19: management and challenges","References":[{"title3":"The cytokine storm and COVID-19"},{"title3":"Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"COVID-19 and liver disease"},{"title3":"COVID-19 and the liver"},{"title3":"Liver Dysfunction Is Associated with Long-Term Mortality in Septic Shock"},{"title3":"Review article: COVID-19 and liver disease-what we know on 1st May 2020"},{"title3":"Gastrointestinal and liver manifestations in patients with COVID-19"},{"title3":"Liver diseases in COVID-19: Etiology, treatment and prognosis"},{"title3":"COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies"},{"title3":"Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis"},{"title3":"Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features"},{"title3":"Clinical characteristics of 82 cases of death from COVID-19"},{"title3":"Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"SARS-CoV-2 Infection in Children"},{"title3":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study"},{"title3":"Clinical Features of COVID-19-Related Liver Functional Abnormality"},{"title3":"Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China"},{"title3":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area"},{"title3":"Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series"},{"title3":"Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China"},{"title3":"Liver tests abnormalities in COVID-19: trick or treat?"},{"title3":"Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic"},{"title3":"Health Status of Patients Who Underwent Liver Transplantation During the Coronavirus Outbreak at a Large Center in Milan, Italy"},{"title3":"COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission"},{"title3":"COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract"},{"title3":"Liver injury in COVID-19: management and challenges"},{"title3":"Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Apoptosis: a mechanism of acute and chronic liver injury"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Proteomics. Tissue-based map of the human proteome"},{"title3":"COVID-19 in a designated infectious diseases hospital outside Hubei Province, China"},{"title3":"Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)"},{"title3":"A literature review for the mechanisms of stress-induced liver injury"},{"title3":"Mechanisms and treatment of organ failure in sepsis"},{"title3":"Liver - guardian, modifier and target of sepsis"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"The emerging role of ACE2 in physiology and disease"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein"},{"title3":"Human neutralizing antibodies elicited by SARS-CoV-2 infection"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes"},{"title3":"The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects"},{"title3":"A phase I trial of intravenous interleukin-6 in patients with advanced cancer"},{"title3":"Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells"},{"title3":"Systemic inflammation as fuel for acute liver injury in COVID-19"},{"title3":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality"},{"title3":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?"},{"title3":"Liver injury during highly pathogenic human coronavirus infections"},{"title3":"SARS-CoV-2: a storm is raging"},{"title3":"In the eye of the COVID-19 cytokine storm"},{"title3":"Viral and host factors related to the clinical outcome of COVID-19"},{"title3":"Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19)"},{"title3":"Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China"},{"title3":"Use of lactate dehydrogenase to evaluate the anti-viral activity against influenza A virus"},{"title3":"Lactate dehydrogenase leakage as a marker for apoptotic cell degradation induced by influenza virus infection in human fetal membrane cells"},{"title3":"Adipokines: molecular links between obesity and atheroslcerosis"},{"title3":"A new perspective on C-reactive protein in H7N9 infections"},{"title3":"C-reactive protein as a biomarker of severe H1N1 influenza"},{"title3":"Cognitive decline in Parkinson disease"},{"title3":"Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019"},{"title3":"Effect of Gastrointestinal Symptoms in Patients With COVID-19"},{"title3":"Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study"},{"title3":"AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19"},{"title3":"Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study"},{"title3":"Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)"},{"title3":"COVID-19 and liver injury: where do we stand?"},{"title3":"Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection"},{"title3":"Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China"},{"title3":"Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement"},{"title3":"COVID-19: Abnormal liver function tests"},{"title3":"Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19"},{"title3":"Hepatic manifestations of COVID-19"},{"title3":"Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies"},{"title3":"Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis"},{"title3":"Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease"},{"title3":"Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study"},{"title3":"Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19"},{"title3":"Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study"},{"title3":"Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations"},{"title3":"Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study"},{"title3":"COVID-19 in solid organ transplant recipients: A single-center case series from Spain"},{"title3":"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter"},{"title3":"COVID-19 in solid organ transplantation patients: A systematic review"},{"title3":"Tocilizumab and liver injury in patients with COVID-19"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor"},{"title3":"A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?"},{"title3":"Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19"},{"title3":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19"},{"title3":"Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir"},{"title3":"Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study"},{"title3":"Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives"},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design"},{"title3":"Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms"},{"title3":"Remdesivir for the Treatment of Covid-19 - Final Report"},{"title3":"Remdesivir for 5 or 10 Days in Patients with Severe Covid-19"},{"title3":"Liver injury in remdesivir-treated COVID-19 patients"},{"title3":"Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019"},{"title3":"Etiology and management of liver injury in patients with COVID-19"},{"title3":"Therapeutic Potential for Tetracyclines in the Treatment of COVID-19"},{"title3":"Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study"},{"title3":"Azithromycin augments rhinovirus-induced IFNbeta via cytosolic MDA5 in experimental models of asthma exacerbation"},{"title3":"Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 Levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis"},{"title3":"Azithromycin for COVID-19: More Than Just an Antimicrobial?"},{"title3":"Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective"},{"title3":"Off-label use of tocilizumab in patients with SARS-CoV-2 infection"},{"title3":"First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19"},{"title3":"Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics"},{"title3":"Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine"},{"title3":"Liver Injury in COVID-19: Caution and Management"},{"title3":"Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review"},{"title3":"Tocilizumab and COVID-19"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Case report on alimentary tract hemorrhage and liver injury after therapy with oseltamivir: A case report"},{"title3":"Polygalasaponin F treats mice with pneumonia induced by influenza virus"},{"title3":"Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study"},{"title3":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro"},{"title3":"The dual protease inhibitor lopinavir/ritonavir (LPV/r) exerts genotoxic stress on lung cells"},{"title3":"Ritonavir and Lopinavir Suppress RCE1 and CAAX Rab Proteins Sensitizing the Liver to Organelle Stress and Injury"},{"title3":"Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature"},{"title3":"Protective effect of bicyclol on lipopolysaccharide-induced acute lung injury in mice"},{"title3":"Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Current pharmacological treatments for COVID-19: What's next?"},{"title3":"Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity"},{"title3":"COVID-19: A review of the proposed pharmacological treatments"},{"title3":"Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis"},{"title3":"Chloroquine attenuates paraquat-induced lung injury in mice by altering inflammation, oxidative stress and fibrosis"},{"title3":"Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055"},{"title3":"The gut microbiota and host health: a new clinical frontier"},{"title3":"Contributions of the intestinal microbiome in lung immunity"},{"title3":"Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19"},{"title3":"Assessment of Renal and Hepatic Tissue-Protective Effects of N-Acetylcysteine via Ammonia Metabolism: A Prospective Randomized Study"},{"title3":"Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?"},{"title3":"Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke"},{"title3":"Could Vitamins Help in the Fight Against COVID-19?"},{"title3":"Role of vitamin E in nonalcoholic fatty liver disease"},{"title3":"Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths"},{"title3":"Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies"},{"title3":"Potential protection of vitamin C against liver-lesioned mice"},{"title3":"Zinc and COVID-19: Basis of Current Clinical Trials"},{"title3":"Zinc and liver disease"},{"title3":"Possibility of magnesium supplementation for supportive treatment in patients with COVID-19"},{"title3":"Magnesium and liver disease"},{"title3":"COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2"},{"title3":"Is copper beneficial for COVID-19 patients?"},{"title3":"Dose-related effects of dexamethasone on liver damage due to bile duct ligation in rats"},{"title3":"Corticosteroids in Acute Lung Injury: The Dilemma Continues"}]},{"title2":"COVID-19 and the liver: little cause for concern","References":[{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"Liver injury in COVID-19: management and challenges"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Liver histology in ICU patients dying from sepsis: a clinico-pathological study"},{"title3":"Systemic viral infections and collateral damage in the liver"},{"title3":"Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis"},{"title3":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial"},{"title3":"Evolution of the immune system in humans from infancy to old age"},{"title3":"Liver cirrhosis is independently associated with 90-day mortality in ARDS patients"}]},{"title2":"novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Epidemiological features and medical care-seeking process of patients with COVID-19 in Wuhan, China","References":[{"title3":"A novel coronavirus emerging in China:key questions for impact assessment"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"A locally transmitted case of SARS-CoV-2 infection in Taiwan"},{"title3":"Journey of a Thai taxi driver and novel coronavirus"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"What to do next to control the 2019-nCoV epidemic?"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"}]},{"title2":"pneumonia in Shanghai, China","References":[{"title3":"Overview of community-acquired pneumonia. Prognosis and clinical features."},{"title3":"Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975."},{"title3":"Community-acquired pneumonia."},{"title3":"Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals."},{"title3":"National Health Commission of the People's Republic of China. China Health Care Statistics Yearbook. 2019. Beijing: Peking Union Medical College Press, 2019."},{"title3":"Economic Burden of Community-Acquired Pneumonia Among Pediatric Patients (Aged 3 Months to &lt; 19 Years) in the Philippines."},{"title3":"Disease burden of community acquired pneumonia among children under 5 y old in China: A population based survey."},{"title3":"Community-acquired pneumonia requiring hospitalization among U.S. children."},{"title3":"Burden of community-acquired pneumonia in adults over 18 y of age."},{"title3":"Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis."},{"title3":"The economice burden of pneumonia and meningitis among children lss than five years old in Hanoi, Vietnam."},{"title3":"Economic evaluation of universal 7-valent pneumococcal conjugate vaccination in Taiwan: a cost-effectiveness analysis."},{"title3":"Community acquired pneumonia: a cost-of-illness analysis in Greece."},{"title3":"Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea."},{"title3":"Pediatric Non-COVID-19 Community-Acquired Pneumonia in COVID-19 Pandemic."},{"title3":"COVID-19 pandemic and the incidence of community-acquired pneumonia in elderly people."},{"title3":"Analysis and reflections on pediatric bed allocation and utilization in Shanghai."},{"title3":"Hospitalization direct cost of adults with community-acquired pneumonia in Portugal from 2000 to 2009."},{"title3":"Community-acquired pneumonia: the annual cost to the National Health Service in the UK."},{"title3":"Analysis on the status of pediatric medical resources and services in Beijing."},{"title3":"Complicated pneumonia in children."},{"title3":"Early appraisal of China's huge and complex health-care reforms."},{"title3":"The hospital of the future in China: China's reform of public hospitals and trends from industrialized countries."},{"title3":". Available online: http://tjj.sh.gov.cn/ysqzzdgk/20190125/0014-1003102.html"},{"title3":". Available online: http://www.gov.cn/xinwen/2019-02/28/content_5369270.htm"},{"title3":"Prevention of community-acquired and nosocomial pneumonia."},{"title3":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults."},{"title3":"Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost?"},{"title3":"Ending of preventable deaths from pneumonia and diarrhoea: an achievable goal."},{"title3":"A systematic review of the serotype distribution of streptococcus pneumonia (pneumococcus) among all cases under 18 years old of pneumococcal infection in China."},{"title3":"The impact of residency and urbanicity on Haemophilus influenzae Type b and pneumococcal immunization in Shanghai Children: a Retrospective Cohort Study."}]},{"title2":"A tool for early prediction of severe coronavirus disease 2019 (COVID-19): a multicenter study using the risk Nomogram in Wuhan and Guangdong, China","References":[]},{"title2":"Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort","References":[{"title3":"Coronavirus disease (COVID-19) outbreak situation"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Fangcang shelter hospitals: a novel concept for responding to public health emergencies"},{"title3":"Clinical progression of patients with COVID-19 in Shanghai, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up"},{"title3":"Diagnosis and treatment protocol for novel coronavirus pneumonia recommended"},{"title3":"Discrimination and calibration of clinical prediction models: users' guides to the medical literature"},{"title3":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis"}]},{"title2":"Clinical characterization of 162 covid-19 patients in Israel: preliminary report from a large tertiary center","References":[]},{"title2":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases"},{"title3":"Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print February 24, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2648."},{"title3":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print February 28, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032."},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"Severe acute respiratory syndrome: clinical and laboratory manifestations"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"SARS immunity and vaccination"},{"title3":"Prevalence, risk factors, and management of asthma in China: a national cross-sectional study"},{"title3":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [published online ahead of print February 19, 2020]. Allergy. https://doi.org/10.1111/all.14238."},{"title3":"An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011"},{"title3":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection"},{"title3":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes"},{"title3":"Wu C, Chen X, Cai Y, Xia Ja, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [published online ahead of print March 13, 2020]. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994."},{"title3":"Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis [published online ahead of print March 26, 2020]. Eur Respir J. https://doi.org/10.1183/13993003.00547-2020."},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published online ahead of print February 24, 2020]. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30079-5."},{"title3":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [published online ahead of print March 18, 2020]. N Engl J Med. https://doi.org/10.1056/NEJMoa2001282."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19 [published online ahead of print February 27, 2020]. JAMA. https://doi.org/10.1001/jama.2020.2783."},{"title3":"Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? [published online ahead of print February 22, 2020] Int J Epidemiol. https://doi.org/10.1093/ije/dyaa033."}]},{"title2":"Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis","References":[{"title3":"World Health Organisation. Interim guidance: Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. 2nd Edition. WHO/2019-nCoV/clinical/2020.4"},{"title3":"Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis"},{"title3":"Liver injury during highly pathogenic human coronavirus infections"},{"title3":"Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia"},{"title3":"COVID-19 and the liver: little cause for concern"},{"title3":"Liver injury in COVID-19: management and challenges"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"R Core Team (2019). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/. Accessed 23 Apr 2020"},{"title3":"meta: an R package for meta-analysis"},{"title3":"Hadley Wickham and Jennifer Bryan (2019). readxl: Read Excel Files. R package version 1.3.1. https://CRAN.R-project.org/package=readxl. Accessed 23 Apr 2020"},{"title3":"Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range"},{"title3":"Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range"},{"title3":"Severe liver failure during SARS-CoV-2 infection"},{"title3":"COVID-19 presenting as acute hepatitis"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection"},{"title3":"Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis"},{"title3":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies"},{"title3":"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study"},{"title3":"Elevated serum levels of alanine aminotransferase and gamm glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome"},{"title3":"Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region"},{"title3":"Acute on chronic liver failure from novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure"}]},{"title2":"Bilirubin levels in patients with mild and severe Covid-19: a pooled analysis","References":[{"title3":"COVID-19 and liver disease"},{"title3":"Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area"},{"title3":"Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study"},{"title3":"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings"},{"title3":"Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"novel coronavirus-infected pneumonia in Wuhan"}]},{"title2":"Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19)","References":[]},{"title2":"Life-saving effect of convalescent plasma treatment in covid-19 disease: clinical trial from eastern Anatolia","References":[{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection"},{"title3":"Convalescent plasma as a potential therapy for COVID-19"},{"title3":"Evaluation of convalescent plasma for Ebola virus disease in Guinea"},{"title3":"Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience"},{"title3":"Treatment for emerging viruses: convalescent plasma and COVID-19"},{"title3":"Food, U. and D. Administration, Investigational COVID-19 Convalescent Plasma-Emergency INDs. Accessed on April, 2020. 8."},{"title3":"Early use of convalescent serum in influenza"},{"title3":"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital"},{"title3":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea"},{"title3":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma"},{"title3":"The convalescent sera option for containing COVID-19"},{"title3":"Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial"},{"title3":"Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection"}]},{"title2":"Analysis of prediction and early warning indexes of patients with COVID-19","References":[]},{"title2":"Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study","References":[{"title3":"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias"},{"title3":"Liver injury during highly pathogenic human coronavirus infections"},{"title3":"Novel coronavirus pneumonia prevention and control program"},{"title3":"Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT"},{"title3":"Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis"},{"title3":"Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia"}]},{"title2":"A novel scoring system for prediction of disease severity in COVID-19","References":[{"title3":"Impact of weight reduction on selected immune system response among Hepatitis C virus Saudi patients"},{"title3":"Middle east respiratory syndrome"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"The Duffy null genotype is associated with a lower level of CCL2, leukocytes and neutrophil count but not with the clinical outcome of HTLV-1 infection"},{"title3":"The effects of viral infection on lymphocyte metabolism: a new perspective on disease characterization"},{"title3":"&quot;Coronaviruses: an overview of their replication and pathogenesis,&quot;"},{"title3":"A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence"},{"title3":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study"},{"title3":"Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage"},{"title3":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Lymphocyte subset (CD4+,CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19"},{"title3":"FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China"},{"title3":"Association between lymphocyte subsets and cytomegalovirus infection status among patients with systemic lupus erythematosus: a pilot study"},{"title3":"Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal"},{"title3":"The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"}]},{"title2":"Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report","References":[]},{"title2":"De Ritis ratio and biochemical parameters in COVID-19 patients","References":[]},{"title2":"An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities","References":[]},{"title2":"Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues","References":[]},{"title2":"The De Ritis ratio: the test of time","References":[]},{"title2":"Review article: COVID-19 and liver disease what we know on 1st May 2020","References":[{"title3":"2019 novel coronavirus:important information for clinicians"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"What to do next to control the 2019-nCoV epidemic?"},{"title3":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms"},{"title3":"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings"},{"title3":"Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up"},{"title3":"COVID-19 in a designated infectious diseases hospital outside Hubei Province, China"},{"title3":"Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical features of COVID-19 related liver damage"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical features and treatment of COVID-19 patients in northeast, Chongqing"},{"title3":"Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study"},{"title3":"Risk factors related to hepatic injury in patients with corona virus disease 2019"},{"title3":"Clinical characteristics of 82 death cases with COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study"},{"title3":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) out-side of Wuhan, China: retrospective case series"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China"},{"title3":"Clinical and biochemical indexes from 2019-nCov infected patients linked to viral loads and lung injury"},{"title3":"Implication of nonalcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis"},{"title3":"Liver injury during highly pathogenic human coronavirus infections"},{"title3":"COVID-19 and Liver dysfunction: current insights and emergent therapeutic strategies"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway"},{"title3":"COVID-19 and the liver: little cause for concern"},{"title3":"Systemic viral infections and collateral damage in the liver"},{"title3":"Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome"},{"title3":"COVID-19 and druginduced liver injury: a problem of plenty or a petty point?"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance"},{"title3":"&quot;Fast, faster, and fastest: science on the run during COVID-19 drama&quot;-&quot;do not forget the liver&quot;"},{"title3":"Influenza virus infection as precipitating event of acute-on-chronic liver failure"},{"title3":"Liver injury in COVID-19: management and challenges"},{"title3":"Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host"},{"title3":"Consensus document on the epidemiology of severe acute respiratory syndrome (SARS)"},{"title3":"Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission"},{"title3":"Coronaviruses and immunosuppressed patients. The facts during the third epidemic"},{"title3":"Highlights for management of patients with autoimmune liver disease during COVID-19 pandemia"},{"title3":"Liver -guardian, modifier and target of sepsis"},{"title3":"Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis"},{"title3":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper"},{"title3":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China"},{"title3":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China"},{"title3":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma"},{"title3":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance"},{"title3":"Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation"},{"title3":"Perioperative presentation of COVID-19 disease in a liver transplant recipient"},{"title3":"Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient"},{"title3":"Fatal outcome in a liver transplant recipient with COVID-19"},{"title3":"COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy"},{"title3":"Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults"},{"title3":"New coronavirus: new challenges for pediatricians"},{"title3":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study"},{"title3":"Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China"},{"title3":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia"},{"title3":"Clinical insights for hepatology and liver transplant providers during the COVID-19 pandemic"},{"title3":"Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019"},{"title3":"Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors"},{"title3":"Safety and pharmacokinetics of lopinavir in HIV/HCV coinfected patients with advanced liver disease"},{"title3":"Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis"},{"title3":"Rethinking the role of hydroxychloroquine in the treatment of COVID-19"},{"title3":"Transaminase levels and hepatic events during tocilizumab treatment: pooled analysis of long-term clinical trial safety data in rheumatoid arthritis"},{"title3":"Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infection"},{"title3":"Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation"},{"title3":"American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy"},{"title3":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection"},{"title3":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects"},{"title3":"Compassionate use of remdesivir for patients with severe Covid-19"},{"title3":"Favipiravir versus arbidol for COVID- 19: a randomized clinical trial"}]},{"title2":"Relationship between COVID-19 infection and liver injury: a review of recent data","References":[{"title3":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"COVID-19: abnormal liver function tests"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study"},{"title3":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper"},{"title3":"Liver injury in COVID-19: management and challenges"},{"title3":"Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19"},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients"},{"title3":"COVID-19 in a designated infectious diseases hospital outside Hubei Province, China"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Clinical features of 85 fatal cases of COVID-19 from Wuhan"},{"title3":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China"},{"title3":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study"},{"title3":"Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up"},{"title3":"Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19)"},{"title3":"Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single centre in Wuhan city, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"C-reactive protein level may predict the risk of COVID-19 aggravation"},{"title3":"COVID-19 in a designated infectious diseases hospital outside Hubei Province, China"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"Review article: COVID-19 and liver disease-what we know on 1st May 2020"},{"title3":"Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Histopathology of middle east respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study"},{"title3":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Clinical characteristics and outcomes of COVID-19 among patients with pre-existing liver disease in United States: a multi-center research network study"},{"title3":"High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry"}]}]}]}